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ABSTRACT
MACHINE LEARNING MODELS FOR DECIPHERING REGULATORY
MECHANISMS AND MORPHOLOGICAL VARIATIONS IN CANCER
May 2021
Saman Farahmand
B.Sc., Shahrood University of Technology
M.Sc., University of Tehran
PhD., University of Massachusetts Boston
Directed By Professor Kourosh Zarringhalam
The exponential growth of multi-omics biological datasets is resulting in an emerg-
ing paradigm shift in fundamental biological research. In recent years, imaging and
transcriptomics datasets are increasingly incorporated into biological studies, pushing
biology further into the domain of data-intensive-sciences. New approaches and tools
from statistics, computer science, and data engineering are profoundly influencing bi-
ological research. Harnessing this ever-growing deluge of multi-omics biological data
requires the development of novel and creative computational approaches. In paral-
lel, fundamental research in data sciences and Artificial Intelligence (AI) has advanced
tremendously, allowing the scientific community to generate a massive amount of knowl-
edge from data. Advances in Deep Learning (DL), in particular, are transforming many
branches of engineering, science, and technology. Several of these methodologies have
already been adapted for harnessing biological datasets; however, there is still a need to
further adapt and tailor these techniques to new and emerging technologies.
In this dissertation, we present computational algorithms and tools that we have
developed to study gene-regulation and cellular morphology in cancer. The models and
platforms that we have developed are general and widely applicable to several problems
relating to dysregulation of gene expression in diseases. Our pipelines and software
packages are disseminated in public repositories for larger scientific community use.
This dissertation is organized in three main projects. In the first project, we present
Causal Inference Engine (CIE), an integrated platform for the identification and inter-
pretation of active regulators of transcriptional response. The platform offers visualiza-
tion tools and pathway enrichment analysis to map predicted regulators to Reactome
pathways. We provide a parallelized R-package for fast and flexible directional enrich-
ment analysis to run the inference on custom regulatory networks. Next, we designed
and developed MODEX, a fully automated text-mining system to extract and annotate
causal regulatory interaction between Transcription Factors (TFs) and genes from the
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biomedical literature. MODEX uses putative TF-gene interactions derived from high-
throughput ChIP-Seq or other experiments and seeks to collect evidence and meta-data
in the biomedical literature to validate and annotate the interactions. MODEX is a
complementary platform to CIE that provides auxiliary information on CIE inferred
interactions by mining the literature.
In the second project, we present a Convolutional Neural Network (CNN) classifier
to perform a pan-cancer analysis of tumor morphology, and predict mutations in key
genes. The main challenges were to determine morphological features underlying a
genetic status and assess whether these features were common in other cancer types. We
trained an Inception-v3 based model to predict TP53 mutation in five cancer types with
the highest rate of TP53 mutations. We also performed a cross-classification analysis to
assess shared morphological features across multiple cancer types. Further, we applied
a similar methodology to classify HER2 status in breast cancer and predict response to
treatment in HER2 positive samples. For this study, our training slides were manually
annotated by expert pathologists to highlight Regions of Interest (ROIs) associated
with HER2+/- tumor microenvironment. Our results indicated that there are strong
morphological features associated with each tumor type. Moreover, our predictions
highly agree with manual annotations in the test set, indicating the feasibility of our
approach in devising an image-based diagnostic tool for HER2 status and treatment
response prediction. We have validated our model using samples from an independent
cohort, which demonstrates the generalizability of our approach.
Finally, in the third project, we present an approach to use spatial transcriptomics
data to predict spatially-resolved active gene regulatory mechanisms in tissues. Using
spatial transcriptomics, we identified tissue regions with differentially expressed genes
and applied our CIE methodology to predict active TFs that can potentially regulate
the marker genes in the region. This project bridged the gap between inference of
active regulators using molecular data and morphological studies using images. The
results demonstrate a significant local pattern in TF activity across the tissue, indicating
differential spatial-regulation in tissues. The results suggest that the integrative analysis
of spatial transcriptomics data with CIE can capture discriminant features and identify
localized TF-target links in the tissue.
v
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Recent advances in biotechnology have resulted in a rapid expansion of available biolog-
ical data. These technologies have enabled biologists to probe tissue samples and cells
at an unprecedented detailed level and generate new biological knowledge on cellular
functions, disease development, and the evolution of species. In parallel, over the past
decade, new methodologies in data sciences have been advancing and data science is
emerging as a new field. The scientific community has generated a multitude of method-
ologies and tools to harness large-scale datasets and generate new knowledge. Recent
advances in the general field of Artificial Intelligence (AI) and in particular in the sub-
branch of Deep Learning (DL), are transforming many branches of engineering, science,
and technology. Many of these techniques have already been adapted for the analysis
of biological datasets. However, there is still a great need to further adapt and develop
new methodologies that are tailored to datasets generated by existing and emerging
biotechnologies. In this thesis, we present several computational algorithms and tools
to analyze molecular and imaging biological data, primarily focusing on gene regulation
and cellular morphology. The main contributions of this thesis are twofold. First, we
present a probabilistic approach and a computational platform to identify active gene
regulatory mechanisms of differential gene expression in a tissue-specific manner. Sec-
ond, we present a deep learning model to identify common tumor morphologies across
cancer types and predict mutations in key genes using cancer images.
This thesis is organized as follows. Chapter 1 contains the relevant biological back-
ground and computational models that are used in the thesis. We start with a brief
introduction to gene regulation and present background material on probabilistic graph-
ical models and convolutional neural networks. In Chapter 2, we present one of our main
results [1], where we introduce Causal Inference Engine (CIE), an integrated platform
that identifies active regulators by running probabilistic queries on biological networks.
The platform consists of a web-server and a user-friendly R-package, providing various
inference models, including methods based on the Fisher’s exact test (enrichment test)
as well as a directional enrichment analysis model that can utilize information on the
mode of regulation (activation vs. repression) [2]. In Chapter 3, we present a hybrid
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text mining model, MODEX, to extract and annotate causal transcriptional regulatory
interactions by mining the biomedical literature in MEDLINE [3]. MODEX is a com-
plementary approach to CIE that incorporates three main text-mining components to
extract auxiliary information on causal regulatory interactions from the literature. The
main components implemented in MODEX are: 1) Information Retrieval (IR), 2) Name
Entity Recognition (NER), and 3) Information Extraction (IE) , which are customized
for mining regulatory interactions form the literature. In Chapter 4, we present our deep
learning approach to perform a pan-cancer analysis of tumor morphology and predict
mutations in key genes [4]. This work was carried out in collaboration with the group of
Prof. Jeffery Chuang at the Jackson Laboratory for Genomic Medicine and the groups of
Prof. David Rimm and Dr. Emily Reisenbichler at Yale University School of Medicine.
The main challenges were to determine morphological features that underlie a given
genetic status and assess whether these features were common in other cancer types.
In Chapter 5, we present a new methodology based on our causal inference model to
identify spatially resolved regulatory interactions in tissues using spatial transcriptomics
data. Chapter 6 summarizes the thesis contributions and concludes the dissertation.
1.1 The Central Dogma of Molecular Biology
The Central Dogma of Molecular Biology defines the canonical direction of the flow
of the genetic information: from DNA to RNA and from RNA to Protein [5]. This
term reflects a sequential biological process that genetic information is read from DNA,
transcribed into an mRNA, and finally translated into a protein, which is the functional
entity in the cellular environment. Deoxyribonucleic acid, DNA, is a long molecule that
is structured in a double-stranded helix and contains the genetic information of the
organism. DNA is composed of four nucleic acids: Adenine (A), Cytosine (C), Guanine
(G), and Thymine (T), that are chained in a base-paired fashion A-T and C-G on a
sugar-phosphate backbone [6].
Transcription is the first step in gene expression, in which genetic information in
a strand of DNA is copied into a new molecule called Ribonucleic acid (RNA) by an
enzyme called RNA polymerase [8]. RNA polymerase employs a single-stranded DNA as
a template to synthesize a complementary strand of RNA in a 5’ to 3’ direction, adding
each new nucleotide to the 3’ end of the strand in the elongation process. Depending on
the organism, there are several types of RNAs, including messenger RNAs (mRNAs),
small RNAs (sRNAs), and long non-coding RNAs (lincRNAs). The mRNA is an RNA
molecule that carries the genetic instructions encoded in the genes, which is needed for
production into proteins. This molecule is processed by a large protein with several
subunits called ribosomes and is synthesized into a protein [9].
The process during which Proteins are produced is called translation. mRNA is
transported outside of the nucleus and decoded by the ribosome to synthesize a specific
amino acid chain that folds into an active protein in the cell [10]. Ribosome translates
the genetic code, a three-letter combination of nucleotides called a codon. Each codon
2
Figure 1.1: An illustration showing the flow of information between DNA, RNA and
protein. Figure taken from [7]
corresponds to an amino acid residue, with redundancy built into the code. Translation
consists of three main stages: initiation, elongation, and termination. The small subunit
of the ribosome is attached to the mRNA molecule during the initiation process. Then,
a transfer RNA (tRNA) carries the amino acid methionine, corresponding to the start
codon (AUG) in the mRNA sequence. Next, the large subunit of the ribosome binds
to the mRNA and the elongation process is started. In this step, each codon is itera-
tively translated into its corresponding amino acid and the amino acid chain is grown,
linked by peptide bonds. Finally, the ribosome reaches a stop codon, which initiates the
termination stage and the newly synthesized protein is released [10].
In the central dogma of biology, gene expression is viewed as a deterministic process
[11]. This process is regulated at every step to address the physiological needs of the cell
and in response to signaling events and environmental changes. Regulation of gene ex-
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pression during transcription is typically referred to as “transcriptional gene regulation”.
Regulation after the gene is transcribed can occur at the RNA level (post-transcriptional
regulation) or at the protein level (post-translational regulation).
1.2 Regulation of Gene Expression
Several mechanisms are employed by cells to activate/enhance or inhibit/repress the
expression of genes. These regulations are needed at virtually every level of cell biol-
ogy, including development, response to signaling or environmental stimuli, and stress
conditions [12]. Gene expression can be regulated in many steps, including transcrip-
tion (DNA→ RNA), post-transcription (RNA level), or post-translation (protein level).
Figure 1.2 illustrates the different stages of gene regulation. Expression of genes can
be regulated by various means, including DNA methylation and Histone modification,
interaction of proteins such as transcription factors (TFs) with specific DNA sequences
to activate or repress genes, RNA silencing, and post-translational modifications. This
complex network of interactions between DNA, RNA, proteins, and compounds that is
used by cells to modulate gene expression is referred to as a “gene regulatory network”
[12]. Transcription factors (TFs) are proteins that interact with the DNA as well as
other proteins according to their structures and dynamics [13, 14, 15], in order to acti-
vate or repress specific genes and play a central role in transcriptional gene regulation
[16]. Sequence-specific TFs activate or repress the production of a gene by binding to
the promoter region or distal regulatory elements called enhancers [12].
Figure 1.2: A diagram illustrating different stages of gene regulation. Figure taken from
[7].
Transcription factors and other regulators work in concert to regulate diverse cellular
processes, including cell cycle, growth, and cell division. Cellular alteration in gene
regulation is observed in diseases such as cancer [12, 17]. Mutations in the genome
can impact transcriptional activity. For example, mutations in enhancer regions or TF
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binding sites can alter TF activity, which impacts gene expression, leading to aberrant
cell growth as observed in cancer cells [12].
1.2.1 Gene Regulatory Network Inference
A gene regulatory network (GRN) is comprised of a set of molecular regulators such as
DNA-binding proteins, miRNAs, and histone modifiers that interact with one another
to modulate gene expression. [18, 19]. GRNs provide a systems view of causal processes
within the cell that occur simultaneously or in cascade to enhance or repress the expres-
sion of specific genes in response to a variety of internal and external events. Deciphering
these regulatory interactions in a context-specific manner can lead to deeper insight into
biological processes and their regulation and can have a direct impact on designing new
therapeutic strategies in diseases such as cancer.
Figure 1.3: Example of a regulatory network. Figure taken from [12]
Many approaches for the reconstruction of GRNs have been proposed by the scien-
tific community [20, 21, 22, 23]. Among the most popular methods are the inference
techniques directly based on gene expression data acquired via high-throughput tech-
nologies such as microarray and RNA-Seq. Microarray is a relatively old technology
that uses tagged probes of oligonucleotides that hybridize with cDNA molecules de-
rived from isolated mRNAs [24]. Probe-target hybridization is usually distinguished
by the identification of labeled targets [25]. RNA-Seq on the other hand, employs
next-generation sequencing (NGS) technology to sequence the cDNA library created
from sample RNAs and directly produces sequencing reads that are then processed and
aligned to the genome to quantify gene expression. Although these technologies are
very different and employ different data preprocessing strategies, they both ultimately
produce “normalized gene expression” data that is processed as an expression matrix
with M rows representing genes, and N columns representing experimental conditions
or samples.
One of the key biological experiments to study the gene regulatory interactions is
called chromatin immunoprecipitation sequencing (ChIP-Seq). The goal of this experi-
ment is to find the DNA-binding location of proteins or transcription factors to target
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genes on DNA to identify regulatory interactions. To briefly explain ChIP-Seq protocol,
they first cross-link all of the proteins bound to DNA. Then, DNA-binding locations are
cut into small fragments, and the target protein (or the transcription factor) is isolated
using a specific antibody. DNA fragments are isolated by washing away the protein to be
used for sequencing the fragments and reading them. Finally, ChIP-Seq data is aligned
to the genome to capture the binding locations and identify nearby genes as its target
regulatory entities. In Chapter 2, we will present a new approach to reconstruct GRNs
using RNA-Seq data derived from tissue samples. Our reconstruction provides tissue-
specific GRNs. We will discuss the similarity and variations of GRNs across tissues and
show how GRNs can be used to identify upstream regulators of genes.
1.3 Digital Pathology
Digital Pathology (DP), is a relatively new paradigm that provides an image-based
digital environment to acquire and analyze glass tissue slides on a massive scale [26].
Digital slides are generated by scanning the glass slides in a high-throughput manner.
The transformation from glass slide to digitized whole slide images (WSI) has enabled
digital image analysis using computational techniques. WSIs are high-resolution images
that are captured by microscopic slide scanners at very high magnification. There are
two main image acquisition approaches that are utilized to generate WSI [27]. In the first
approach, small overlapping tiles from the output sensor are merged together to generate
the whole slide, while in the second approach a linear scan is performed to generate
long image strips [28]. These tiles or stripes are then stitched together to generate a
single large gigapixel-resolution WSI. These images are viewable on a microscopic scale
at different magnifications including 5×, 10×, 20×, and 40×. WSIs used in digital
pathology are typically stored in TIFF [29] or SVS [30] formats and tend be much larger
in size than those used in other applications such as radiology.
Before images are produced, tissues are typically stained with certain chemicals to
make specific cellular structures in the cell visible (e.g., cellular membrane or the nucleus)
[31]. There are several staining techniques that are employed for various applications.
Among the most widely used staining methods is Haemotoxylin and Eosin (H&E) stain-
ing. Eosin is an acidic and negatively-charged dye that binds to the proteins within
the cytoplasm, producing a pink color. On the other hand, Hematoxylin is a basic and
positively-charged dye that binding to the nucleus and RNAs in ribosomes, producing
a purple color [31]. Hematoxylin and Eosin (H&E) is the most widely used method for
routine pathological diagnostics as it encompasses a broad range of cytoplasmic, nu-
clear, and extracellular matrix features in the images. Figure 1.4 shows a skin tissue
slide stained by Haematoxylin and Eosin.
The vast amount of digitally stored WSI together with the advances in deep learning
are revolutionizing the field of digital pathology. Several breakthrough technologies have
been developed to automate the analysis of histopathology images for a wide variety
of applications, including diagnosis and informing treatment modalities [26, 33]. In
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Figure 1.4: Skin tissue H&E slide example. The nuclei are stained purple, while the
cytoplasmic components are pink. Figure taken from [32]
Chapter 4, we present one such technique that utilizes H&E slides to examine common
morphological features in cancer and predict mutations in key genes.
1.3.1 Spatial Transcriptomics
Spatial transcriptomics is a general term, encompassing several technologies that map
gene expression to the location of cells within the tissue. Tissue architecture and prox-
imity of cells to one another can have a big impact on the profile of gene expression.
Although bulk and single-cell RNA-Sequencing capture gene expression in a population
or in individual cells, they are not able to map this information to locations within the
tissue. This information can be critical for understanding the pathology of diseases [?].
New and emerging breakthrough technologies have been developed that are capable of
measuring the expression of genes in multiple regions within a tissue. Some of the no-
table methods include multiplexed error-robust FISH (MERFISH) [34], sequential FISH
(seqFISH) [35, 36] 10X spatial transcriptomics (ST) [37] and Slide-seq [38].
Spatial transcriptomics (ST) uses barcoded oligo-deoxythymidine (oligo-dT) to tag
cells across many tissue regions, that are then multiplexed and sequenced. Using these
barcodes, cells and expression of the genes are then mapped to the location from which
the cells originate (Figure 1.5) [39]. Although this technology is quite powerful, the
resolution is still limited to the transcriptomes of ∼ 5 to 10 neighboring cells. Single-cell
resolution in spatial transcriptomics would be a remarkable feat, allowing inference of
biological processes at the cellular level within the tissue [39].
In Chapter 5, we will present a new methodology to infer active regulatory mecha-
nisms across tissue location using spatial transcriptomics data. We identify differential
gene expression patterns across the tissue and apply our causal reasoning techniques to
identify localized regulatory mechanisms. This methodology can shed light on the un-
derlying mechanisms of dysregulation of gene expression in a spatially resolved manner
and can further aid in deciphering the pathology of diseases using spatial transcriptomics
data.
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Figure 1.5: Spatial Transcriptomic (ST) approach. Spatial transcriptomic profiling of
tissue slides using spatially barcoded oligo-deoxythymidine (oligo-dT) microarray. Fig-
ure taken from [40]
1.4 Gaussian Graphical Modeling
Probabilistic graphical models (PGMs) refer to a framework for modeling random vari-
ables and their conditional dependence using directed or undirected graphs [41]. Graph-
ical models use techniques from both graph theory and probability theory to model
the joint distribution of a large number of random variables. A special subclass of
PGMs are Gaussian Graphical Model (GGM), where the collection of random variables
X = (X1, · · · , XL) in the graphs are assumed to follow a normal distribution N (µ,Σ)
with unknown mean vector µ and covariance matrix Σ [42]. Given observations (samples)
from the random variable X, it is possible to use the method of maximum likelihood
(MLE) to directly estimate the covariance matrix Σ and the inverse covariance matrix
(also referred to as the precision matrix) Σ−1. Following the conditional independence
property of GGMs, it can be shown that the precision matrix encodes the conditional
dependence between the random variables in the graph, hence providing a way to infer
the graph structure and the partial correlation between the random variables. A key ad-
vantage of partial correlations is that it identifies direct connections between the random
variables in the graph and indirect connections through tertiary nodes will not produce
false edges in the network. This property is quite useful when the dependency structure
between the random variables is unknown. For example, gene-gene interaction networks
or protein-protein interaction networks can be inferred through this technique [43, 44].
The mathematical framework of GGM is presented in the excellent review by Uhler [42].
In Chapter 2, we provide a novel penalization approach in fitting the GMM that allows
us to integrate gene-expression data from tissue samples with TF-gene interaction data
from ChIP-Seq studies to construct tissue-specific TF-gene regulatory networks.
1.5 Natural Language Processing
Natural Language Processing (NLP) refers to a set of algorithms and techniques to pro-
cess unstructured text and human languages. NLP seeks to produce methodologies for
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reading, translating, and ultimately interpret human language using a computer. Text
mining is a branch of NLP that uses algorithms to mine raw text and textual con-
texts to extract information [45]. NLP is extensively used in Biomedical and Molecular
Biology domains to extract knowledge from the vast amount of biomedical literature.
This field is referred to as Biomedical text mining or BioNLP. One of the main tasks
in BioNLP is to extract structured biological knowledge that involves biological entities
of compounds (e.g., interactions between drugs and proteins). Figure 1.6 shows the
main phases involved in biomedical text mining: 1) Information Retrieval (IR), 2) Name
Entity Recognition (NER), and 3) Information Extraction (IE).
Figure 1.6: Conventional phases and tasks involved in biomedical text mining. Figure
taken from [45].
IR tools retrieve relevant text information from articles, abstracts, paragraphs, and
sentences corresponding to subjects of interest. A popular IR approach for biomedical
application is the use of Boolean model logic (AND/OR) for extracting relevant informa-
tion containing specific biological terms [46]. Prominent IR tools that use the Boolean
logic model are iHOP [47] and PubMed.
After the IR step, NER is used to identify biological entities (e.g., genes, proteins,
etc.). This is a challenging step as entity names are not unique. Therefore, NER tools
must take textual context into consideration to accurately detect entities. For example,
gene names may have different variations in orthographical structure (e.g. ABL1, Abl1,
Abl-1) or multiple synonyms (e.g. ABL1, ABL, CHDSKM, Abelson tyrosine-protein
kinase 1). ER methods, typically divide the task into two steps, 1) identify the entities
and their location in the context and 2) assign unique identifiers to the entities [46].
Fortunately, multiple terminological databases, such as Gene Ontology [48], UMBLS,
BioLexicon, and Biothesaurus [49] exist that provide information on biological entities
and name variations and can be used to detect biological entities [50].
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Lastly, Relation Extraction (RE) is a task for extracting pre-defined facts relating to
an entity or entities in the text [51]. In biomedical domain, multiple RE methods have
been developed to extract information relating to genes [52], such as Mutation-Disease
associations, protein-protein interaction [53, 43], pathway curation [54], gene methylation
and cancer [55], biomolecular events [56], metabolic reactions and gene-gene interactions
[57].
In Chapter 3, we present a text-mining approach for extraction of causal relation
between a protein and a gene (e.g., A regulated B). This task is very complex to mine
a huge textual database to extract target information by human or even by general
computational techniques. it is sometimes difficult for human experts to identify a causal
relation manually from a long paragraph [58]. Our text-mining approach complements
our causal inference methodology for identifying active regulatory mechanisms by mining
the literature to collect prior knowledge on the inferred TF-gene interaction.
1.6 Deep Learning
Several of the techniques presented in subsequent chapters rely on probabilistic models
and Machine learning approaches. Machine learning is now a fairly established and piv-
otal “learning-framework” that is utilized in many areas of science and engineering. Ma-
chine learning algorithms are able to address many of the shortcomings of conventional
methods through the use of novel feature extraction techniques and flexible nonlinear
parameterizations [59, 60, 61, 62].
Deep learning is a branch of machine learning inspired by the structure and function
of the human brain. Deep learning is an extension of classical feed-forward neural net-
works [63], where modifications to the architecture of the network are applied for more
efficient use of the parameter space and abstraction of the data [64]. Figure 1.7 shows a
conventional four-layer feed-forward neural network.
Deep learning architectures have shown exemplary performance in several competi-
tive tasks, including Computer Vision and Image Processing [66, 67, 68], Protein folding
[69], natural language processing [70], and many others. Two of the main approaches
in deep learning are Recurrent Neural Networks (RNNs) and Convolutional Neural Net-
works (CNNs) [71, 72]. RNNs are memory-aware architectures that are able to model
dynamic processes with time dependence [73]. On the other hand, CNNs, inspired by
the animal visual cortex, are static networks that are mainly applied to automatically
extract features from images. These features are used for various image classification and
segmentation tasks [71]. In this thesis, we utilize CNNs extensively to analyze cancer
images.
CNNs are similar to classical feed-forward neural networks in the sense that they are
comprised of a set of connected neurons and a set of weights and biases [74]. However,
they differ significantly in structure and architecture and the use of weights. CNNs
consist of repeated blocks of neurons with shared weights that are convolved with the
input image. This process can be thought of as “learning a filter” that extracts abstract
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Figure 1.7: A classical four-layer feed-forward neural network (taken from [63]). The
model consists of an input layer i, hidden layers j and k, and an output layerm. Neurons
in each layer are directly connect to all other neurons in the next layer through a series of
weights (W ). Neurons are activated based on their input values and activation function,
to generate the output which is the input to the subsequent layer. The information
flows forward through the network to generate the final output of the ANN. ANN can
be trained using optimization methods [65].
features from the image. This is quite advantageous over classical pattern recognition
method, where image features are manually engineered [64]. A simple CNN architecture
is generally comprised of repetitive convolutional and pooling layers that are eventually
connected to a feed-forward ANN for a specific task (e.g., classification) [75]. The con-
volutional layers consists of a set of convolutional kernels (or filters) that are convolved
with the input matrix [76]. Given an input image x and a filter W of size h × w, the
(discrete) convolution is calculated by summing the element-wise products between the
image and the filter [76]. Outputs of multiple convolutional filters can themselves be
processed by another set of convolutional filters. These higher-level convolutional filters
tend to detect larger patterns in the original image. Figure 1.8 shows the main compo-
nents of a CNN architecture.
The pooling layer is another crucial step in CNN, which acts as a non-linear down-
sampling operator to reduce the number of parameters while capturing the important
features correlated with the output task [78]. The goal of the pooling step is to capture
a combination of features that are invariant to translational shifts and small distortions
[79]. The pooling layer also lowers the computation workload by reducing the spatial
size of the feature map and reduces the risk of overfitting the model [79].
As mentioned, the terminal component is typically a fully connected feed-forward
11
Figure 1.8: Convolutional Neural Network basic architecture. Figure taken from [77].
ANN with encoded non-linear transformations that are used for the required task [79].
LeCun et al. [75] created the first CNN model that was used for handwritten pat-
tern recognition. Ever since, several extensions have been proposed that considerably
increased the efficiency and accuracy of CNNs. Some of these extensions include AlexNet
[80], VGGNet [81], ResNet [82], and GoogleNet [83]. An important factor in deep learn-
ing architectures is the depth of the network. AlexNet introduced multiple convolutional
layers stacked on top of one another that are able to extract more abstract features from
an image. VGGNet uses deeper networks and generally performs better for image clas-
sification tasks. It should be noted that very deep architectures are hard to train due to
a large number of parameters and model performance can deteriorate [84]. ResNet [82]
addresses this shortcoming by creating residual connections from one layer to the next.
GoogleNet [83] introduced a new architecture using “inception module” that tremen-
dously decreases the number of model parameters in the network, and utilizes average
pooling instead of fully-connected layers in upper layers to eliminate a large number of
parameters. In Chapter 4, we present deep learning approach based on GoogleNet to




CAUSAL INFERENCE ENGINE: A
PLATFORM FOR DIRECTIONAL
GENE SET ENRICHMENT ANALYSIS
AND INFERENCE OF ACTIVE
TRANSCRIPTIONAL REGULATORS
2.1 Introduction
The material in this chapter are taken from my publication in Nucleic Acid Research 2019
[1]. Technological advancements in high-throughput sequencing have made it possible to
measure expression of genes at a relatively low cost. However, the direct measurement of
regulatory mechanisms, such as transcription factor (TF) activity, in a high-throughput
manner is still not readily available. Consequently, there is a need for computational ap-
proaches that can identify active regulatory mechanisms from observable gene expression
data. The scientific community has developed a multitude of algorithms and biophysical
models to study the impact of TF activity on gene expression. Some of these algorithms
attempt to infer TF activity and dynamics directly from gene expression data [85]. Oth-
ers rely on biophysical approaches to model expression of genes based on known TF-gene
interactions [86]. Another class of algorithms, which are the main focus of this work,
use prior biological knowledge on biomolecular interactions to link a differential gene
expression (DGE) profile to upstream regulators (e.g., TFs) [87, 88, 89, 90]. The essen-
tial ingredients of these algorithms are (i) a DGE profile, (ii) a network of biomolecular
interactions, and (iii) an inference algorithm to query the network.
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2.1.1 Gene Regulatory Network Reconstruction using DGE profile
The DGE profile as obtained from RNA-Seq or microarray studies is the observable in-
put and quantifies the difference in transcript abundance between two conditions (e.g.,
healthy vs. disease, stimulated vs. not stimulated, etc.). The network of biomolecular
interactions encapsulates the prior biological knowledge. The accuracy and ability of
inference algorithms to identify upstream molecular drivers of observed DGE profiles
rely to a large degree on the quality and coverage of the network and availability of
auxiliary information on interactions within the network. There are several sources of
publicly available protein-protein interactions and signaling pathways (e.g., STRINGdb
[91], Pathway Commons [92], Kyto Encyclopedia of Genes and Genomes (KEGG) Path-
ways [93], etc.). In case of regulatory networks, Ingenuity [94] provides a high-coverage
manually-curated network of regulatory interactions in an integrated platform, Ingenu-
ity Pathway Analysis tool [87]. Among other things, this platform provides pathway
inference, enrichment analysis functionality and network visualization tools. However,
the Ingenuity tools are inaccessible for the majority of academic applications and there
is a need for freely available alternatives for academic purposes.
Several approaches for reconstruction of regulatory networks form gene expression
data have been proposed by the scientific community. These approaches can be broadly
categorized as 1) co-expression based approaches [95, 96], 2) non-steady state approaches
based on time-series analysis [97], and 3) text-mining approaches [98]. In co-expression
based approaches, the objective is to identify gene-regulator interactions by analyzing
correlation patterns using a variety of methods, including direct correlation, partial cor-
relation (e.g., using GGMs) [99], mutual information based methods [100], and Bayesian
network reconstruction methods [101]. A limitation of these approaches is that the re-
covered interactions are typically associative (undirected). Methods based on non-steady
state approaches typically attempt to infer the dynamics of gene-regulator interactions
and can yield more accurate results [102]. However, they require time-course gene expres-
sion data across multiple conditions, which may not be readily available. Text-mining
based methods attempt to extract interactions from biomedical literature. "There is
vast body of literature on these approaches and several data-bases include interactions
obtained from text-mining methods" [52]. These approaches, however, typically yield
low coverage and assessing false positives can be very challenging. It should be noted
that several of the aforementioned methods utilize other sources of information as prior
knowledge to increase the accuracy of the recovered network. In particular methods
based on interventional data (e.g., single gene KO) are very promising [103]. However,
these approaches are tailored for a specific condition or particular pathways and gener-
alization to multiple conditions is currently infeasible.
Consequently, several public sources of gene regulatory interactions are derived from
aforementioned computational and experimental approaches. These sources include the
Transcriptional Regulatory Element Database (TRED) [104], the Transcription Regu-
latory Regions Database (TRRD) [105], and Transcriptional Regulatory Relationships
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Unraveled by Sentence-based Text Mining (TRRUST) [98]. These databases provide
valuable information on gene regulatory mechanisms [106], but drawbacks exist. The
scope of the databases containing experimentally validated interactions are very small,
and cover only a fraction of TF-gene interactions. On the other hand, databases of
computationally predicted and expression-driven interactions are typically very noisy.
Importantly, the majority of the databases do not report the direction of regulation (ac-
tivation vs. repression) - which is crucial to understanding the functional behavior of
the cell.
In this chapter, we present Casual Inference Engine (CIE), a platform for active
regulator inference on biological networks consisting of a web-server and a user-friendly
R-package. The platform provides various inference models, including methods based
on Fisher’s exact test (enrichment test) as well as directional enrichment models that
can utilize information on mode of regulation [90]. Moreover, we present an approach
based on regularized Gaussian Graphical Models (GGM) to construct an accurate and
high-coverage annotated networks of TF-gene regulatory interactions. We achieve this by
integrating publicly available high-throughput ChIP-Seq experiments deposited in ChIP-
Atlas [107] with tissue specific gene expression data from GTEx [108]. The key differences
of our approach from previous approaches include: 1) TF-gene interactions derived from
ChIP-Seq experiments are utilized to construct a penalty matrix encoding the prior
causal graph of TF-gene interactions. 2) The penalty matrix is utilized to regularize
the log-likelihood of a GGM constructed from tissue-specific gene expression data, from
which a posterior TF-gene interaction is constructed. The design of the regularization
is such that the GGM essentially eliminates the interactions in the prior ChIP-network
that are not supported by the expression data, resulting in posterior tissue-specific and
causal ChIP-networks. 3) An additional advantage is determination of the mode of
regulation of the posterior interactions, resulting in network of annotated tissue-specific
TF-gene interactions. 4) In addition to tissue specific interactions, we provide cross-
tissue interactions, i.e., interactions that appear in multiple tissues. 5) Subsequent
integrated algorithms in the CIE platform for directional enrichment analysis, designed
to identify active transcriptional regulators of differential gene expression data provides
a comprehensive pipeline for analysis of transcriptional regulators.
We show the consistency and accuracy of our reconstructed network by benchmark-
ing against manually curated interactions in the gold standard databases. We demon-
strate the utility of our platform in identifying active regulators using controlled in vitro
overexpression studies as well as more complex gene expression data from a stem cell dif-
ferentiation experiment. Additionally, we show how our platform can assist in identifying
novel transcriptional regulatory mechanisms using gene expression data from primary
prostate fibroblast cells stimulated with TGFβ and CXCL12. Although our focus in
this work is on transcriptional regulatory networks, the R-package provides functionality
to perform inference on any type of user provided network. The CIE platform provides
higher-order pathway enrichment analysis on identified active regulators using Reactome
pathways [109]. Figure 2.1 shows a schematic overview of the CIE platform.
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Figure 2.1: CIE platform for inference of active regulators [1]. CIE takes a user provided
DGE profile as input (left panel). User selects a prior regulatory network from the
provided databases. In the server side (middle panel), the input is processed and the
Shiny app calls R functions to perform the inference analysis based on the user selected
options. Predicted active regulators associated with the DEG profile are displayed with
interactive graphics and are downloadable in table format (right panel). CIE also offers
pathway enrichment analysis by mapping the inferred regulators to pathways from the
Reactome database.
2.2 MATERIALS AND METHODS
2.2.1 Regulatory network
The interaction network can be viewed as a graph G = (V,E), consisting of a set of
nodes V (biological entities) and a set of edges E = (u, v). The network is not limited
to interactions between TFs and genes and can include other types of interactions (e.g.,
interactions between compounds and proteins, protein-protein interactions, etc.). Some
of these edges may be associations (an undirected edge u− v, indicating change in u is
correlated with change in v), causal (a directed edge u→ v, indicating that u regulates
v) or signed causal (with + or −, indicating mode of regulation).
2.2.2 Databases
We utilized three sources of TF-gene interaction networks. Our criterion for inclusion
was that they either must include high-confidence, manually curated interactions with
literature support or must have direct experimental evidence. These sources are:
(A) The TRRUST database: TRRUST [98] is a manually-curated database of human
transcriptional regulatory network derived from PubMed articles with partial informa-
tion on mode of regulation. It contains 9,396 regulatory interactions between 795 human
TFs and 2,067 target genes.
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(B) The TRED database: TRED [104] is an integrated repository for regulatory ele-
ments in mammals with experimental evidence. It includes a total of 6,726 interactions
between 36 TF and 2,910 genes. These interactions are not annotated with mode of
regulation.
(C) ChIP-Seq derived TF-gene interactions: We obtained all publicly available ChIP-
Seq data ( > 96,000 experiments) that are processed and deposited into ChIP-Atlas [107].
A TF-gene interaction network was assembled by merging all experiments and applying
various filters for peak signal intensity (0-1,000) and distance to the transcription start
site (TSS) (1kb, 5kb, and 10KB). These filters are integrated in the CIE platform and
can be applied interactively in the web-app. For example, peak intensity score of 500
and distance of 5kb to TSS results in 185,271 interactions between 642 TFs and 16,148
target genes. Note that ChIP-Seq network does not directly provide information on
mode of regulation and all TF-gene interactions in this database are unannotated.
(D) STRINGdb: In addition to TF-gene interactions, we also included Protein-gene in-
teractions from STRINGdb [91]. STRINGdb includes protein-protein interactions (PPI)
from various sources including curated, experimentally supported, and computationally-
derived interactions. Some of the interactions are causal and annotated, but most inter-
actions in the STRINGdb are undirected. For each undirected PPI u−v, we constructed
two directed interactions u→ v and v → u.
We provided these regulatory networks as selective options for users in the CIE
platform to be used as prior knowledge in causal inference algorithm.
2.2.3 Differential Gene Expression Profiles.
We used several DGE profiles from microarray and RNA-Seq experiments to evaluate
the utility of our platform. For microarray data, gene expression profiles were normal-
ized and differentially expressed genes were computed using the R limma package [110]
or other approaches [111, 112, 113]. We applied a 1.5 arbitrary value fold change and
< 0.05 FDR corrected p-value filter for selecting differentially expressed genes. RNA-Seq
data was processed using the HISAT2 [114] pipeline and differentially expressed genes
were identified for each treatment the edgeR package [115]. Similar filters for FDR and
fold change were applied to identify differentially expressed genes. The data sets that
we utilized for our evaluation are:
(A) Controlled overexpression experiments. We utilized three datasets from [116], in
which recombinant antiviruses were used to infect normal human epithelial cell in order
to overexpress specific oncogenes. The over expressed genes are E2F3, c-Myc and H-Ras.
There are 272, 220 and 268 differentially expressed genes compared to the WT in the
experiments respectively.
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(B) Stem cell directed differentiation. We used a time-course in vitro differentiation
model of pancreatic beta cell development from [117]. NEUROG3+ Pancreatic progen-
itor cells convert to NKX2-2+ endocrine cells, which are able to further differentiate
into fully-functional insulin producing cells upon implantation into mice [118]. A total
of 1,000 differentially expressed genes were identified from this dataset.
(C) fibroblast phenotypic plasticity. We utilized data from RNA-Seq experiments per-
formed on prostatic stromal fibroblasts stimulated with Vehicle, TGFβ, and CXCL12
[119]. A total of 10,032 differentially expressed genes were identified in fibroblasts treated
with TGFβ or CXCL12. The DGE profile of TGFβ and CXCL12 were 75% similar (7,502
transcripts). A total of 1,012 (10%) were induced by TGFβ treatment only and 1,357
(13%) by CXCL12 treatment only. 161 (2%) were differentially regulated in opposite
directions by CXCL12 and TGFβ.
2.2.4 Construction of transcriptional regulatory networks
The network constructed from ChIP-data is not consistent as the experiments are per-
formed under various conditions in different cell lines. Moreover, the interactions are not
annotated with mode of regulation (activation vs. repression). To reduce the noise and
annotate the interactions, we utilized a regularized Gaussian Graphical Model (glasso)
[120] to integrate the ChIP-derived network with tissue specific RNA-Seq data obtained
form the Genotype-Tissue Expression project (The GTEx Consortium) [108]. Processed
normalized gene expression values were obtained from [121], where GTEx RNA sequenc-
ing reads from 15 tissues from 2,585 paired-end RNA-Seq samples were re-processed,
uniformly realigned, and normalized to remove batch effects and tissues with low num-
ber of samples. Every ChIP-derived interaction was taken account without any filters
(≈ 4×106 interactions). To construct the tissue-specific annotated regulatory networks,
we estimated a sparse covariance matrix using each tissue-expression data separately,
while softly enforcing ChIP-derived interaction using an `1 penalty matrix. Gene ex-
pression was log transformed prior to analysis. Only protein-coding genes were utilized
and genes with no one-to-one map between Ensemble ID and HGNC symbol were ex-
cluded.
The process of constructing a posterior network form gene expression data and ChIP-
network is as follows. Let S denote the empirical covariance matrix estimated from the
RNA-Seq expression data for a given tissue, Σ be the (unknown) covariance matrix, and
Θ = Σ−1 be the precision matrix. Glasso directly estimates the precision matrix Θ by
maximizing the `1 penalized log likelihood
L = − log (det Θ) + tr(SΘ) + kΛ||Θ||1, (2.1)
on the space of positive semi-definite matrices. Here Λ is a shrinkage parameter matrix
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and k is a scaler tuning parameter. The prior ChIP-network structure was incorporated
in the penalty as follows. First, we constructed an adjacency matrix A from the ChIP-
network. The rows and columns of A were arranged by TFs first and then by genes. If
there is a connection between transcription factor i and gene j the corresponding entry
in the adjacency matrix is set to 1 (i.e., Aij = 1), and otherwise it is set to 0. The
penalty matrix Λ has the same size as the adjacency matrix. The entries of this matrix
are constant values and are set to differentially penalize the connections based on the
information in the adjacency matrix as follows:
Λij =

λd i = j;
λs i 6= j; Aij = 0,
λp i 6= j; Aij 6= 0.
(2.2)
In our implementation, diagonal elements were not penalized (i.e., λd = 0). Interact-
ing TFs and genes (i.e., ., Aij = 1) were penalized by a small nonzero value (λs = 0.05)
and non-interacting pairs were penalized by a relatively large value (λp = 0.5). The
matrix was then scaled by a constant value k. We utilized a path of values ranging from
1 to 6 with step size 0.1 for k. For each scaling value, we fitted the model by maximiz-
ing the log likelihood and calculated the corresponding precision matrix Θ, from which
a posterior regulatory network was constructed based on the conditional independence
property of GGMs [42]. More precisely there is a connection between TF i and gene j
if and only if Θij ≥ ε. The threshold value ε was selected 1e − 4 empirically as a small
value. For each posterior network, we calculated the scale-free property using the R-
squared (R2) value between log(p(d)) and log(d) , where p(d) represents the proportion
of nodes in the network with d interactions [122]. We chose a value of k for each tissue
that generated the highest R2 value. Figure 2.2 illustrates the approach. Once the final
posterior network was constructed, the signs of the interactions were determined using






, i 6= j (2.3)
Note that the connections in each posterior network are supported by both ChIP-
Seq data as well as by partial correlation of gene expression values. A total of 15
tissue-specific posterior network were constructed using this process. Additionally, we
examined the overlap between these networks to identify the connections that appear
across multiple tissues. Such connections can be viewed as consistent universal inter-
actions. We refer to these network as merged networks. In our implementation, we
constructed merged network using interactions that are consistent in at least 2, 3, 4, or
5 tissues.
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Figure 2.2: Assembly of tissue-specific regulatory networks. The empirical covariance
matrix was estimated from GTEx tissue-specific gene expression data. ChIP-Atlas prior
network was converted into an adjacency matrix of prior TF-gene interactions and softly
enforced into graphical lasso using a penalty matrix Λ with various degrees of stringency.
The sparse precision matrix Θ was estimated by optimizing the penalized log likelihood,
from which the posterior network was constructed. The precision matrix encodes the
direct interaction between entities in the network. A non-zero value Θij ≥ ε indicates
that there is an interaction between ith TF and jth target gene. The sign of interac-
tion (activation vs. repression) is calculated from the partial correlation matrix. This
schematic is inspired by Figure 1 in [122].
2.2.5 Inferring active regulators
CIE provided several (directional and un-directional) enrichment tests to query the net-
works and identify transcriptional regulators from a user provided DGE profile. The
starting point of the inference is selection of one of the causal networks of interactions
that are provided by CIE. The type of inference depends on the availability of informa-
tion on the mode of regulation in the causal graph. The first method is the Fisher’s
exact test or the enrichment scoring (ES) statistic, which is the standard for gene set
enrichment analysis [123]. This method does not take information on mode regulation
into account. The next enrichment method is Ternary scoring (TS) statistic proposed by
Chindelevitch et. al. [90]. This method is suitable for fully annotated networks. For net-
works with a mixture of annotated and unannotated edges, we utilized the Quaternary
scoring (QS) statistic proposed by Fakhry et. al .[89].
All these methods are build on a common core, calculating the goodness of the fit
of the score, which measure the agreement between predictions made by regulators in
the graph and the observed DEG profile. For each regulator in the selected network, a
contingency table is constructed that tabulates the agreement between the predictions
made by the regulator according to the graph and the observations based on the DGE
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profile. The rows of the table represent the prediction made by the regulator and the
columns represent observed differential expression profile. In case of the Enrichment
scoring statistic, a 2 × 2 contingency is constructed, with rows representing genes that
are predicted to be regulated, or unregulated by the regulator according to the network,
and the columns representing genes that are observed to be regulated, or unregulated
according to the observed DGE profile. In case of Ternary scoring statistics a 3 × 3
contingency table is constructed, with rows representing genes that are predicted to be
upregulated, downregulated, or unregulated by the regulator and the columns represent
genes that are observed to be upregulated, downregulated, or unregulated according
to the DGE profile. Finally, in case of Quaternary scoring statistic a 4× 3 contingency
table is constructed in a similar manner with an additional row representing regulated or
unregulated corresponding to unsigned edges in the network. The statistical significance
of the score is calculated using a permutation (generalized hyper-geometric) test and the
p-values are reported (see supplementary Figure S6 for the details of inference algorithm).
2.2.6 The CIE web server
The CIE web server was implemented using R Shiny, Docker, ShinyProxy, and a NGINX
web server. The applet RCytoscapeJs was used for network visualization. The core of
functionality of the web server is driven by the CIE R package. The open-source version
of Shiny is a single-threaded web server for web applications implemented with R. If it is
used to run a web application that takes a few seconds at most to load, this will not cause
any noticeable impairment. However, CIE takes up to several minutes to load and the
open-source Shiny web server cannot allow another user to connect during this time as
it can only do one task at a time. To overcome this limitation, we used ShinyProxy and
Docker container to allow creation of multiple instances. ShinyProxy detects a new user’s
request and starts a Docker container of CIE application specifically for the user. NGINX
takes the request from the user and forwards it through reverse proxy to ShinyProxy. The
CIE web server is located at ‘https://umbibio.math.umb.edu/cie/app’, and is accessible
by all major browsers. The inference result table consists of the regulator’s symbol,
total number of target genes, number of the significant target genes (i.e., differentially
expressed genes), and the corresponding p-values. The result table can be downloaded in
a text format. Users can also run higher-order pathway enrichment analysis by mapping
the inferred regulators to Reactome pathways [109].
2.2.7 The CIE R-package
We also provide CIE R-package for offline and local usage available to download at
‘https://github.com/umbibio/CIE-R-Package’, under the GNU public license. The pack-
age is capable of producing the same plots and results as the web server with a simple
function call and allows for more fine-tune control, automation, and customized input
networks. The CIE R package is parallelized to provide efficient and fast inference. It
utilizes the multidplyr and dopar packages to implement this parallel computation. Mul-
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Figure 2.3: Histogram of the predicted interactions including positive and negative mode
of regulations referring to activation and repression respectively for each tissue.
tidplyr allows the table of statistics from which enrichment is calculated to be produced
quickly, and dopar calculates the p-values in parallel by wrapping a function call to
their calculator. Our package is documented and includes a comprehensive manual and
instructional vignettes.
2.3 RESULTS
We performed our GGM approach to integrate ChIP-derived network from ChIP-Atlas
[107] with tissue-specific gene expression data from GTEx [108] (Figure 2.3). For each
tissue, a grid of regularization parameters was applied, and the best network based on
the highest R-squared value was selected.
2.3.1 Summary statistics
We examined the overlap between recovered interactions in each tissue. Figure 2.4A
shows the number of recovered regulatory interactions shared between tissues. Inter-
actions that appear across several tissues are called consistent and reflect non-tissue
specific, universal TF-gene interactions. As expected, we observed a significant drop in
number of consistent interactions as number of tissues increase. There are a total number
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of 95,745 interactions between 739 TFs and 14,660 genes that appear across at least 5
tissues out of 15 tissues used to construct tissue-specific networks. We further examined
the consistency of recovered signs (mode of regulation) across tissues. This analysis was
carried out on interactions that appear in at least 5 tissues. For each interaction, the
proportion of times that the interaction was annotated as positive (or negative) across
the tissues in which the interaction appeared was calculated. Completely consistent in-
teractions will have either positive proportion of 1 (i.e., recovered always as positive) or
0 (i.e., recovered always as negative). Figure 2.4B shows the frequency of the positive
proportions. As can be observed the distribution is bimodal, with most interactions re-
covered consistently as either positive or negative, indicating that TF-gene interactions
tend to be activation or repression independent of the tissue. For cross-tissue merged
networks, a majority voting scheme was used to annotate inconsistent interactions. Note
that other possible ways to determine cross-tissue merged networks and their sign would
be some statistical measurements (e.g., binomial tests) which might be less noisy. We
set an interaction to neutral sign or unannotated interaction if we had equal recovered
signs in the tissues.
Furthermore, we investigated the optimal networks selected by the cross-validation
strategy, and similar pattern can be observed between recovered interactions among
tissues. In this analysis, we used gene expression data for each tissue and the graphical
model to calculate the guassian distribution parameters including covariance matrix and
inverse of the covariance matrix (precision matrix). Then, we used these parameters to
calculate likelihood for the other tissues in a cross-measurement scheme. In order to
clearly show the distance between the likelihoods in a heatmap, we normalized them by
shifting the largest likelihood to 1 and normalized the rest relatively between 0 and 1.
The cross tissue analysis of fitted likelihoods indicates that the recovered interactions
have high tissue specificity (Figure 2.5). The heatmap shows that the highest likelihood
are determined in diagonal elements reflecting the tissue-specificity of the networks. It
should be mentioned that for some tissues like Thyroid, the test result shows relatively
high likelihood values. It shows that this network covers most of the interactions with
similar configuration and regulatory directions (partial correlations) with respect to other
networks. Figure 2.3 shows that Thyroid network has the second largest number of
interactions along with the others. This reason may also address some of the non-
symmetrical patterns observed in cross tissue likelihood analysis in Figure 2.5.
2.3.2 Benchmark results
We compared our inferred mode of regulation with the signs reported in the TRRUST
and STRING databases including high-quality and manually-curated sources of human
TF-gene interactions, which can be considered as the gold standard for our purpose.
For this benchmark, we merged all annotated interactions across all tissues. Figure
2.6a shows the number of posterior interactions and their associated sign distribution































Figure 2.4: A) Number of interactions shared across tissues. B) Proportion of positive
interactions shared in at least 5 tissues. The bimodal distribution shows that interactions
are consistently annotated as positive (1.0) or negative (0).
supported by a tissue specific gene expression data and annotated by our GGM approach
(Figure 2.6A top). The final sign of recovered interactions were decided according to a
majority voting scheme resulting in 55% positive and 45% negative interactions (Figure
2.6A top). We compared the sign of annotated interactions with the signs reported in the
TRRUST and STRING databases as a gold standard. The overlap between the ChIP-
network and the gold standard is 5,701 TF-gene interactions (Figure 2.6A bottom), of
which 2,619 are annotated in both gold standard and the tissue corrected ChIP-network.
Further restricting the interactions in the ChIP-network to consistent interactions that
appear across at least 3 tissues, results in 390 overlaps with gold standard interactions.
Figure 2.6B shows classification performance of these 2,619 and 390 overlapping inter-
actions between 3-tissue merged (corrected) ChIP-networks with the gold standard. As
can be seen the agreement is high in both cases (F1-scores 0.74 and 0.92), demonstrating
that our approach and 3-tissue merged network is highly accurate in identifying signs of
regulation.
2.3.3 Recovering known perturbations in controlled overexpression experiments
To test the performance of our tissue-corrected ChIP-network and inference algorithms,
we used the CIE platform to identify drivers of differential expressed genes in controlled
overexpression studies [116]. The study used human primary mammary epithelial cell
cultures (HMECs) to develop three oncogenic pathways’ deregulation. For this anal-
ysis, we utilized three differential expression profiles, all of which were obtained by
over expressing an oncogene. The genes are E2F3, c-Myc, and H-Ras. The number of
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Figure 2.5: Cross tissue likelihood analysis to investigate tissue specificity of the regula-
tory networks.
differentially expressed genes in experiment are 272, 220 and 268 respectively. In this
experiment, we used tissue-corrected ChIP-network to perform the causal inference anal-
ysis since we did not have a prior regulatory network for this particular cell type. Table
3.4 outlines the top 10 regulators predicted by CIE on each experiment sorted by the
FDR corrected p-values (< 0.05) of the enrichment statistics (ES). The FDR corrected
p-values of the Ternary score (TS) along with the predicted direction of regulation by
the Ternary method are also presented in the table.
In the case of E2F3 experiment, E2F1 is returned as the top putative regulator along
with E2F2 as another top regulator. E2F1, E2F2, and E2F3 are close related family of
transcription factors with very similar roles that function to control the cell cycle and
are implicated in cancer [124]. The direction of regulation for these factors are correctly
predicted as upregulated by Ternary method. Another predicted regulator is EZH2,
which is a downstream of the pRB-E2F pathway and is essential for prolifiration and
amplified in several primary tumors [125]. Interestingly, the Ternary method predicts the
direction of regulation of CEBPD as down. It is documented that CEBPD reverses E2F1-
mediated gene repression and increased level of CEBPD attenuates E2F1-induced cancer























Accuracy F1 Precision Sensitivity Specificity
All annotated interactions
Consistent interactions in at least 3 tissues
Figure 2.6: (A) Summary statistics of annotated interactions in the ChIP-network and
overlap with gold standard. (B) Classification performance of annotated interactions in
ChIP-network compared with gold standard.
of the top putative regulators and it is predicted to be upregulated. CIE also predicted
WDR5, a required interactor of MYC that associates with the same target genes in vivo
and is implicated in driving tumorigenesis [127]. Finally, in the H-Ras experiment, EGR1
is among the top putative regulators returned by the algorithm with a significant p-value
and predicted to be upregulated. EGR1 is a key regulator of oncogenic processes and
is downstream of H-RAS [128]. In all cases the biology behind the recovered regulators
is sufficiently evident, demonstrating the ability of the CIE platform and the tissue
corrected ChIP-network in recovering correct regulators of differential gene expression.
Note that Quaternary score is equal to Ternary score when we have annotated in-
teractions only. Quaternary score is useful for mixed signed and unsigned graphs. For
completely unsigned graphs, Quaternary is equivalent to Fisher’s exact test. Ternary
(and Quaternary) scores are generally more stringent than the enrichment score. Unlike
the enrichment score, they also match the direction of regulation between the network
and the DEG profile. Additionally, the Ternary and Quaternary are able to make infer-
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Table 2.1: Top 10 predicted regulators by CIE on tissue corrected ChIP-network
Columns: Predicted regulator (Name), FDR corrected p-value (Enrichment Score: ES
and Ternary Score: TS), predicted direction of regulation (Reg.)
ence on the direction of perturbation of the predicted active regulators.
2.3.4 Drivers of stem cell directed differentiation
To test the utility of the CIE platform and the higher-order pathway enrichment on
inferred regulators in generating biological insight, we utilized a more complex data set
of stem cell directed differentiation of pancreatic beta cells [117] and the mixed signed
STRINGdb network with Quaternary scoring method. Figures 2.7A and B show the
CIE causal regulatory inference results using STRINGdb as prior regulatory network.
Note that we do not have pancrease-specific ChIP-network to be used in this analy-
sis. Among the top predictors, Gastrin (GAST), IL6 and NEUROG3 are predicted to
be up-regulated by CIE, all of which are involved in the development of the pancre-
atic endocrine cell lineage [129]. Users can interactively select top regulators predicted
by CIE and perform pathway enrichment analysis using the Reactome [109] pathways.
Figure 2.7C shows the enriched Reactome pathways returned by CIE using the top 5
predicted regulators. Several significant pathways were acquired through this analysis
such as regulation of gene expression in late stage (branching morphogenesis) pancreatic
bud precursor cells, which is essentially pointing to the endocrine differentiation of the
epithelial cells [130]. Furthermore, Regulation of beta-cell development is also identified,
which provides a direct link to the transient cellular stages leading to the generation of
all pancreatic endocrine cells including insulin-producing beta cells [130]. Finally, tran-
scriptional regulation of pluripotent stem cells is identified, which encodes regulatory
networks underlying Embryonic stem cells (ESCs) differentiation into any cell type or
tissue type in body [131].
2.3.5 Signaling mechanisms underlying fibroblast-to-myofibroblast
phenoconversion.
In this section we show how the CIE platform can be utilized to test a specific biological
hypothesis regarding transcriptional regulators. We demonstrate this use case in the









Interleukin-4 and Interleukin-13 signaling 0.0004
Regulation of gene expression in late stage pancreatic bud precursor cells 0.0027
POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation 0.0027
Transcriptional regulation of pluripotent stem cells 0.0094
Regulation of beta-cell development 0.0153
Signaling by Interleukins 0.0153
Interleukin-10 signaling 0.0183
Senescence-Associated Secretory Phenotype (SASP) 0.0183
Developmental Biology 0.0317
Cytokine Signaling in Immune system 0.0317







Figure 2.7: CIE output on differentiation of pancreatic beta cell. A) Inferred regulatory
network corresponding to top 5 predicted regulators and their target genes. B) Table
of top 5 predicted active regulators. C) Reactome pathways corresponding to the top 5
predicted regulators by CIE.
the human connective tissue and play a primary role in secretion of the components of
the extracellular matrix (ECM) [132]. Fibroblasts have striking similarities with mes-
enchymal stem cells (MSCs) and share some functions with MSCs, including phenotypic
plasticity governed at the genetic level [133]. It is known that Fibroblast can pheno-
typically convert to myofibroblasts in response to pro-fibrotic proteins such as TGFβ
and CXC-type chemokines, secreted by the aging and/or inflammatory cells [119]. Phe-
notypic conversion can occur through two independent cellular signaling mechanisms:
One that depends upon TGFβ/TGFβR axis activation and Smad singling, and another
that depends upon CXCL12/CXCR4-axis activation, EGFR transactivation, and down-
stream signaling through MEK/ERK and PI3K/Akt pathways - all of which converge
in the nucleus to promote the expression of multiple collagen genes [134].
It was reported that TGFβ and CXCL12 induced or repressed a transcriptional
molecular signature that was 75% similar and 25% dissimilar [119]. There is evidence
that both TGFβ and CXCL12 may be acting upon the same set of bHLH (basic Helix-
Loop-Helix) E-box and Egr-1/Egr-2 TFs that bind to consensus sequences in the pro-
moters of the COL1A1 and COL1A2 and other genes [135]. To test this hypothesis we
utilized the DGE profiles from the RNA-Seq experiments for both TGFβ and CXCL12
treatment [119] and performed a CIE analysis using Ternary scoring statistic and merged
tissue-corrected ChIP-network.
The algorithm predicts many active regulators. Notably,AHR, BHLHE40, TCF4,
TCF12, ARNT, ARNTL, MYC, and NEUROG2 bHLH transcription factors, and
Egr-1, Egr-2 transcription factors are predicted by the algorithm as top putative regu-
lators. We also examined the promoter of COL1A1 and COL1A2 and identified multiple
binding sites for several of these TFs, including AHR, Egr-1, BHLHE40, ARNT, TCF4.
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In particular, Egr-1 has multiple binding sites in the promoters of these genes. Taken
together, these results support the hypothesis that Egr- bHHL-family TFs can drive the
expression of collagen genes in response to TGFβ and CXCL12.
2.4 Conclusion and discussion
In this chapter, we present Causal Inference Engine (CIE), an integrated platform for
identification and interpretation of active regulators of transcriptional response. The
platform offers visualization tools and pathway enrichment analysis to map predicted
regulators to Reactome pathways. We provide a parallelized R-package for fast and
flexible directional enrichment analysis that can run the inference on any user provided
custom regulatory network. Multiple inference algorithms are provided within the CIE
platform along with regulatory networks from curated sources TRRUST and TRED as
well as a causal protein-gene interactions derived from the STRINGdb. Importantly we
provide a high confidence annotated causal transcriptional regulatory network by com-
bining publicly available ChIP-Seq data with tissue specific gene expression data. Using
a novel regularized gaussian graphical model, we softly enforce the TF-gene interaction
identified by ChIP-Seq experiments in estimating the precision and partial correlation
matrices form tissue gene-expression data, from which we drive tissue-specific annotated
transcriptional regulatory networks. Further by merging the networks, we obtained a
set of consistent TF-gene interactions that are universally applicable independent of
the context. Benchmarks against the gold standard TRRUST database demonstrate
that our approach is well able to recover mode of regulation with high accuracy. We
demonstrated the utility of our approach in discovering known and novel biology using
controlled in vitro over-expression studies as well as stem cell differentiation. Moreover,
we demonstrated how our platform can be utilized to investigate specific biological hy-
potheses of transcriptional regulatory mechanisms in the context of fibroblast phenotypic
plasticity in response to signaling events.
It should be discussed here that the causal inference algorithms used in this version of
our platform, are enrichment-based methods (these algorithms are not part of this thesis
contribution). These methods highly rely on the prior regulatory network to perform
inference analysis. One of the confounding factors in these algorithms is overlapping
target genes in the prior network that might introduce false positive to the prediction.
For instance, in the section 2.3.3, E2F3 has 968 target genes in the tissue-corrected
ChIP-network, and E2F1 has 898 target genes. They shared 49 unique target genes
between them which might add error to the algorithms. Note that Bayesian methods
can be used to address this limitation.
Our approach and platform can be adopted for other settings, such as identifying
candidate co-activators of specific transcription factors and reconstructing regulatory
networks from single cell gene expression data. We hope that this platform provides
the scientific community an open source alternative tool to interpret differential gene
expression and to generate new biological insights. In the future, we plan to integrate
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additional networks and pathway inference methods in our platform. We also plan to




MODEX: A TEXT MINING SYSTEM





The material in this chapter are taken from my publication in the Journal of Biomedical
Informatics, 2019 [3]. Gene regulatory networks are essential in many cellular processes,
including metabolism, signal transduction, development, and cell fate [136]. At the
transcriptional level, regulation of genes is orchestrated by concerted action between
Transcription Factors (TFs), histone modifiers, and distal cis-regulatory elements to
finely tune and modulate expression of genes. Sequence-specific TFs play a key role
in regulating gene transcription at the transcriptional level. They bind specific DNA
motifs to regulate promoter activity and either enhance (activate) or repress (inhibit)
expression of the genes. Deciphering transcriptional regulatory networks is crucial for
understanding cellular mechanisms and response at a molecular level and can shed light
on molecular basis of complex human diseases [137, 111, 112, 106]. Moreover, knowledge
on interactions between genes and biomolecules is an essential building block in several
pathway inference and gene enrichment analysis methods that aim to annotate an altered
set of transcripts with biological function [138].
A high-throughput experimental approach for identifying regulatory interaction is
chromatin immunoprecipitation followed by sequencing (ChIP-Seq). In ChIP-Seq method-
ologies, antibodies that recognizes a specific TF are used to pull down attached DNA
for sequencing. The ENCODE (Encyclopedia of DNA Elements) consortium [139] has
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produced vast amount of publicly available high-throughput ChIP-Seq experiments that
are processed and deposited into databases such as GTRD [140] and ChIP-Atlas [107]
(>40,000 human experiments). These databases can be utilized to construct a high
coverage transcriptional regulatory network. There are also other sources of transcrip-
tional regulatory network including JASPAR [141], the Open Regulatory Annotation
database (ORegAnno) [142], SwissRegulon [143], the Transcriptional Regulatory Ele-
ment Database (TRED) [144], the Transcription Regulatory Regions Database (TRRD)
[105], TFactS [145], TRRUST [52]. These databases have been assembled with a variety
of approaches, including reverse engineering approaches based on high-throughput gene
expression experiments [146, 113], text mining approaches [147], and manual curation
[148].
Although these databases are a valuable source of gene regulatory information, there
are several constraints that limit their usability. For instance, databases of computation-
ally predicted and expression-driven interactions are typically very noisy. Importantly,
the majority of the databases including ChIP-derived databases do not report the mode
of regulation (up or down) - which is crucial to understanding the functional behavior
of the cell. In this study, we propose a text mining system ModEx, to mine biomedical
literature and annotate ChIP-derived regulatory interactions.
As we mentioned in Chapter 1, text mining plays an important role in unveiling
purified information from a large number of documents in a satisfactory time. Essential
steps for biomedical text mining can be divided into 3 steps: (1) information retrieval
(IR), (2) name entity recognition (NER), and (3) information extraction (IE). Together,
they can be utilized to identify specific biological knowledge from literature. Construc-
tion of a causal transcriptional regulatory network by traditional means of text mining
is hampered by several challenges discussed in section 1.4.2 and as a result, fully auto-
mated text-mining based models are limited in their scope and accuracy [46]. Combining
experimentally derived regulatory interactions from high-throughput sources with text-
mining approaches can bridge the gap between the two approaches and address their
shortcomings.
In this chapter, we present a hybrid model ModEx, to mine the biomedical litera-
ture in MEDLINE to extract and annotate causal transcriptional regulatory interactions
derived from high-throughput ChIP-seq datasets. Our model incorporates three main
components of IR, NER and IE customized for mining regulatory interactions. Several
expert-generated dictionaries are provided to optimize and complement the IR compo-
nent. We proposed a weighted long-range dependency graph to extract causal relations
and annotated the retrieved interaction with meta-data, such as full supporting sen-
tences, PubMed ID, and importantly mode of regulation. Our pipeline bypasses several
of the challenges of fully automated text-mining methods, including query translation for
a particular interaction, relevant citation retrieval, entities recognition and regulatory
annotation. ModEx was able to achieve an F-score 0.76 in retrieving and annotating
a gold-standard regulatory network. We also compared ModEx with a state-of-the-art
method, and the result shows strong improvement in terms of classification metrics.
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The rest of the chapter is structured as follows. We describe the datasets and present
the details of the proposed information extraction and event extraction components and
introduce our regulatory mode extraction using a long-range dependency graph. Next,
system evaluation and benchmark results are presented in Result section. Finally, we
conclude the chapter and discuss the result, limitations, and future work.
3.2 Materials and methods
3.2.1 Datasets
We obtained TF-gene interaction data from ChIP-Seq experiments, deposited on the
ChIP-Atlas database [107]. ChIP-Atlas contains all publicly available high-throughput
ChIP-Seq experiments. We assembled regulatory networks from these interactions using
various cutoff criteria for ChIP-Seq peak signal score and distance to the TSS. The least
stringent criterion results in a network with 4 million interactions between 758 TFs and
18,874 target genes. However, there is no reported mode of regulation in ChIP-Atlas.
We used PubMed engine to query the MEDLINE database using the entities involved
in interaction in ChIP-Atlas. MEDLINE is openly accessible and provides more than
25 million biomedical and life sciences references from approximately 5,600 worldwide
journals. PubMed takes a query including keywords from user, and returns a list of
citations that match input query.
Finally, TRRUST regulatory network [148] was utilized as gold standard to evalu-
ate the performance of ModEx. TRRUST is a manually curated database of human
transcriptional regulatory network with partial information on mode of regulation. It
contains 9,396 regulatory interactions of 800 human transcription factors, 5,066 of which
are annotated with information on mode of regulation (3,148 repression and 1,918 acti-
vation).
3.2.2 Information retrieval module
We developed an IR module, using Biopython [149], to retrieve the information from the
MEDLINE for regulatory interactions in ChIP-Atlas. Figure 3.1 illustrates the overall
workflow of our IR module to fetch relevant citations associated with the regulatory
interaction. We start by building a query based on the entities participated in the
interactions to retrieve abstracts from PubMed engine. PubMed engine takes free-text
keywords and returns a list of ranked citations that match input keywords. Its search
strategy has two major characteristics: first, it adds Boolean operators into user’s query
and then uses automatic term mapping (ATM) [150].
Each query was supplemented with extra terms acquired from several external re-
sources, including HGNC, Entrez, and UniprotKB to fetch more relevant abstracts. We
integrated these synonyms into a local dictionary covering gene symbol, synonyms and
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Figure 3.1: The Information Retrieval workflow. The steps are as follows: first, a
Boolean query is built according to the associated entities in the regulatory interaction.
It uses our local dictionary integrated from several external databases to complement
the query with more synonyms and aliases. Then, the query is submitted to the PubMed
engine and abstracts are retrieved for processing. Abstracts with no regulatory events
are excluded for further analysis.
the ATM in order to increase the chance of attaining relevant citations and also to reduce
the response time. The query was made with appropriate Boolean logic (AND/OR) on
entities and their extra terms using the lookup dictionary. A MeSH descriptor term (e.g.
Humans) was also incorporated in the query to further boost the mapping process on
PubMed engine. For examples the query for AATF and MYC regulatory interaction is,
“humans [msh] AND (AATF[sym] OR BFR2[sym] OR CHE-1[sym] OR CHE1[sym] OR
DED[sym] OR apoptosis antagonizing transcription factor [GFN] ) AND ( MYC[sym]
ORMRTL[sym] ORMYCC[sym] OR BHLHE39[sym] OR C-MYC[sym] ORMYC proto-
oncogene [GFN] )”. Note that there is no limit on the number of synonyms (ranging
from 0 to 18) used in the query. Accessing our local dictionary is executed rapidly on the
client side for this purpose. To estimate the cost of expanding the original query with
synonyms and aliases, we compared the turnaround times of both queries on a TRRUST
database. Figure 3.2 shows the boxplot of turnaround time for both queries. As can be
seen, the time difference is trivial.
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Figure 3.2: Box plot of turnaround time for expanded and original PubMed query on
TRRUST database.
Finally, a dictionary-based approach was used to exclude irrelevant abstracts by scan-
ning individual elements of them. We generated two sets of “causal regulatory events”
including positive (activation) and negative (repression) events to purify the final ab-
stracts. We applied a filter on retrieved abstracts and included only those abstracts
which contain at least one regulatory event as presented in Table 3.1. Each category
contains more than 50 verbs and their inflections. Note that we implemented a com-
putational technique to generate different inflections of these verbs. For example, the
AATF-MYC query outlined above, resulted in 4 relevant abstracts (PMIDs: 20549547,
17006618, 17006618, 20924650).
Table 3.1: Regulatory events categories.
Category No. Events Examples
Positive 500 increase, induce, activate, enhance
Negative 511 reduce, decrease, suppress, block
3.2.3 Gene and regulatory entity recognition
The next step in the pipeline is to identify biological entities within the abstracts. Figure
3.3 shows the NER module of our system. Two external state-of-the-art NER systems
were utilized to annotate the retrieved abstracts with an accurate and complete list of
biological entities. The first system is PubTator [151], a web-based system for assisting
biocuration. PubTator utilizes a HTTP REST interface, equipped with multiple state-of-
the-art text mining algorithms to run query. Using this system, we queried the abstract
PMIDs from IR module to PubTator interface and obtained entity annotations in a
JSON encoded text. Additionally, we utilized BeCAS [152] (another online NER tool)
to improve the coverage of the entities. BeCAS, like PubTator, provides a RESTful












Annotating causal events 
Figure 3.3: The gene entity and regulatory event recognition workflow. Each PubMed
ID retrieved by IR component are submitted to the external NER tools (PubTator and
BeCAS) for annotating genes in the abstracts. It follows complementary annotations
using our internal NER component including a lookup table for covering acronyms, and
a similarity search to identify lexical variations for gene names.
or PMIDs and returns associated annotations as an XML document. Although both
systems provide high consistent annotations for gene entities, we put more priority on
PubTator when there is incompatible results for a particular entity.
To further enhance the NER module, we implemented and added an additional NER
component as follows. Abstracts were normalized to uppercase format and searched
for gene acronyms using a manually-curated lookup table [153]. This table includes
long term / short term pair association to recognize entities, which were missed by the
external NER tools. For instance, AR is a short term for “Androgen Receptor” and was
only detected as an entity (transcription factor) using this lookup table. Furthermore,
we utilized a name similarity metric to identify strings with lexical variations such as
whitespace and punctuations. For instance, “IL-12” and “IL12” are two lexical variations
of “Interleukin 12”. The former version was not identified by the External NER systems.
In our implementation, we set the entity detection threshold based on Jaro similarity
[154] of 0.9 or larger between the query entity and the string in the abstract.
Finally, we normalized the annotated word or a group of words corresponding to
a gene to their HGNC symbol for simplification of downstream analysis. Regulatory
events were also annotated using our expert-generated categories (Table 3.1). Figure
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3.4 illustrates the normalization of gene names and annotation of regulatory events.
Importantly, in order to reduce noises, sentences that contained no regulatory event
were excluded from further analysis. We used the remaining sentences from all citations
to extract relation between the TF and target gene.
Figure 3.4: An example of gene entity normalization and regulatory events annota-
tion. All of the words or group of words associated to target entities (purple color)
are normalized to their HGNC symbol for simplification. Causal regulatory events also
are annotated according to their categories, and sentences with no regulatory event are
excluded for further consideration.
3.2.4 Extracting mode of regulation
Figure 3.5 illusterates the steps of the relation extraction workflow of our system. For
each causal interaction, its annotated sentences from NER module were submitted to
the Stanford dependency parser [155] and a dependency parse tree was generated. De-
pendency trees extracted from different sentences were merged into a single large graph.
The merging process is straightforward; each dependency relation includes one head
word/node and one dependent word/node. Nodes from different dependency relations
representing the same word were merged together. PMID was recorded for each edge in
the parse tree to indicate its source of evidence. Furthermore, each edge in the parse
tree was assigned weight which is the number of occurrences of dependency relations
with respect to all of the evidence sentences. The rational for using this weighted parse
tree is that it can be used to identify long-range dependency relations across sentence
boundaries that would otherwise be missed. Absolute frequency of a dependency rela-
tion obtained from the merging step can somewhat reflect the semantic relation of the
head word and the dependent word.
RE module creates candidate relations by extracting subtrees with common ancestors
connecting the pair of query genes as leaves. These subtrees must contain at least one
causal event describing the candidate relation between the given pair of genes. Subtrees
were extracted by applying a Depth First Search along with a Boolean visited array to
avoid possible loops. Nodes with two paths to the entities were considered as a root of
the subtree. Next, we utilized a rule based approach to describe relations using three
commonly used language constructs [51]. The first rule is effector-relation-effectee (e.g.
A activates B). The second rule is relation-of-effectee-by-effector (e.g. Activation of A
by B). These rules were applied to both paths from root to query entities to identify
their regulatory dependency. Figures 3.5b and 3.5c illustrate the regulatory relation

























































Figure 3.5: Relation extraction workflow extraction workflow. Panel (a) shows the
construction of a long-range dependency graph by merging all of dependency trees cor-
responding to the evidence sentences. The weights of the graph reflect the number of
occurrences of dependency relations. Candidate regulatory signs are identified using
common subtrees with at least one regulatory event in the graph. Finally, a sign of reg-
ulation is assigned to the query interaction through the ranking task. panel (b) shows
an example for simple rule (effector-relation-effectee) in which the RE system can assign
a positive sign to this candidate pattern. In panel (c), we can see the impact of the
negation rule to extract accurate sign to this pattern. Two paths from root to query
entities contain negative regulatory events which carries an activation/positive sign for
the pattern. For a more clear example, please also look at Figure 3.6.
which cannot be captured by these language constructs. To address this, we incorporated
a negation rule to increase the performance of the RE system. For example, consider
the following sentence: “LMP1 suppresses the transcriptional repressor ATF3, possibly
leading to the TGFβ-induced ID1 upregulation” [156]. In the first pass the system
assigns a positive mode to the interaction between ATF3 and ID1. However, there is a
negative interaction between the TF and target gene. The negation rule considers the
negative event “suppresses” related to ATF3 and switch the positive mode to negative.
Figure 3.5c shows a subtree reflecting the negation rule.
We then apply the rules to every subtree to extract the mode of regulation between
the query genes. The weights of the graph encode repetition of regulatory relations
across sentences and abstracts. we considered the weights when there was more than
one regulatory event associated with the target gene. In this case, an event with higher
weight was selected for ranking the subtree. We also considered distance of events to
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Figure 3.6: Example of relation extraction method using two example. The figure shows
two sentences demonstrating the positive interaction between AATF-MYC by construct-
ing a long-range dependency graph and processing target subtrees.
the target gene when the weights in the subtree were equal. The closest event to the
target entity will take the highest priority for determining the interaction mode. Finally,
we investigated regulatory mode in every candidate subtree and assigned a total mode
of regulation to the interaction using a voting scheme. Figure 3.6 shows an example of
relation extraction logic from two sample sentences. Algorithm 1 shows the algorithm
used in ModEx to identify mode of regulation.
Algorithm 1 Algorithm for extraction of mode of regulation from evidence sentences.
select a list of evidence sentences S for interaction between t and g
dependency graph G(V,E)← {}
for s in S do
d← dependencies(s)
G← merge(G, d)
G is a weighted graph encoding repetition of dependencies
for v in G(V,E) do





visited{V ′} ← True







mtotal ← vote(all mv extracted from G)
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3.2.5 ModEx HTTP interface
We implemented an HTTP REST server for users to programmatically annotate gene
regulatory networks using ModEx. Clients should make HTTP requests to the server
with a particular format, specifying the query entities and optional MeSH term to an-
notate. The query has to be requested in the following format: TFEntrezIDTarge-
tEntrezIDMeSHterm. For instance, a query to the server for AATF-MYC should be
formatted as “/modex/26574_4609_humans”. Similar queries can be constructed by
changing the Entrez ids. The server returns extracted annotation along with associated
citations and sentences in XML format if any evidence exists. The turnaround time
varies based on entities from one minute to a few minutes. For example, the server can
be queried for the sample query AATF-MYC:
https://watson.math.umb.edu/modex/26574_4609_humans.
3.3 Results
3.3.1 Impact of NER component
We tested the performance of different NER components of ModEx on gold-standard
dataset provided by BioCreative V shared task 4 [157]. The dataset contains 7,555 man-
ually annotated gene entities from 11,066 sentences from PubMed. For this experiment,
we applied the NER system to sentences and compare the recognized gene entities with
gold standard. We used two external NER components Pubtator and beCAS as stan-
dalone system, and evaluated their performance with our complementary internal NER
functions (Section 3.2.3). We also report the performance of ensemble system including
all of the components that we used in ModEx. Figure 3.6 shows the performance of
various NER components of ModEx.
The results indicate that all the systems achieved precision more than %67 for gene
term extraction. Except for standalone BeCAS most other systems achieved very high
recall. Note that we only investigated the performance of the systems on annotating
gene entities. Although, our internal NER module compensated for the limitations of
the external NER components, we did not observe a substantial increase in recall with
marginal decrease in the precision of term extraction. Indeed, we achieved the highest
performance in terms of F1-measure 81.7 using the ensemble NER system in ModEx.
3.3.2 Classification performance
We evaluated the performance of our method using the TRRUST database, a manually
curated network or regulatory interaction with partial information on mode of regula-
tion. TRRUST is a high-quality database and can be considered as gold standard for
our benchmark. We applied our method to 5,066 regulatory interactions in TRRUST for
which information on mode of regulation was available. As a benchmark, we developed
























Figure 3.7: The performance result of five NER systems on the extraction of gene entities
from gold standard.
(INDRA), a state-of-the-art text mining pipeline in biomedical domain, [158]. INDRA
is an automated model assembly system interfacing with NLP systems and databases
developed for molecular systems biology to collect knowledge and describe molecular
mechanisms. In our approach, INDRA was used to assemble a reasoning model using
causal statements extracted from literature through its submodules and methods. We
configured INDRA to only extract, annotate and assemble a rule-based model to iden-
tify regulatory information from PubMed. The following steps were taken to assemble
the pipeline. First, we used INDRA to mine PubMed using our expanded query for
regulatory interactions. We then extracted all of the INDRA statement from returned
abstracts using two standalone parsers, REACH [159] and TRIPS [160]. Finally, we
incorporated all of the statements to assemble a reasoning model using PySB [161], a
model assembler that implements a mathematical procedure to build a rule-based ex-
ecutable model. We identified inferred regulatory activity from the assembled model.
Table 3.4 shows a summary of output of performing ModEx and INDRA on TRRUST
database. INDRA identified PubMed abstracts corresponding to 4,942 of the annotated
regulatory interactions in TRRUST, while ModEx extracted 4,884 abstracts due to an
additional filtering step based on regulatory events in the IR module (Section 3.2.2).
ModEx and INDRA detected 4,225 and 3,093 regulatory activity (mode) respectively
that are divided into activation and repression. We compared 3,077 interactions of inter-
section between the ModEx and INDRA results with the reported regulatory activities
in TRRUST database. Figure 3.8 outlines the classification performance of ModEx and
INDRA to identified mode of regulation. The result shows that our method outperforms
41
Figure 3.8: Classification results of ModEx and INDRA on TRRUST.
Table 3.2: Summary statistics of performing ModEx and INDRA on TRRUST.
INDRA with F1-Measure 0.76 in prediction of mode of regulations.
3.3.3 ChIP-Atlas analysis
We next sought to extract and annotate ChIP-seq derived TF-gene causal regulatory
interactions from literature using our system. Such meta-data and evidence from lit-
erature can increase the confidence in the TF-gene interactions identified by ChIP-seq
experiments and further shed light on the mechanism of interaction. Information on
mode of regulation in particular can be helpful to enhance the accuracy of enrichment
algorithms for regulatory pathway inference.
We applied ModEx to ChIP-seq interactions, with moderately stringency criteria,
i.e., binding distance within 1k of the TSS and ChIP peak score > 950, resulting in
43,444 interactions. The system was able to detect and annotate 1,592 of interactions
in PubMed database. Table 3.3 outlines the summary of output result on ChIP-Atlas.
Some of the retrieved annotated ChIP-seq interactions also appear in the TRRUST
database (69 total), indicating the low coverage of the TRRUST database. We compared
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Figure 3.9: Classification results of ModEx on intersection on TRRUST and ChIP-Atlas.
the identified mode of regulations of ChIP-Seq interactions with the reported ones in the
TRRUST database. Figure 3.8 summarizes the classification results. As can be seen the
agreement is very high, indicating that our method can reliably identify and annotate
ChIP interaction when they are reported in literature. Additionally, we compared our
acquired evidence (PMIDs) by ModEx with citations reported in TRRUST. Our IR
module was able to fetch the relevant evidence from PubMed database with accuracy
0.88.
Table 3.3: Summary statistics of performing ModEx on ChIP-Atlas.
3.3.4 Directional enrichment analysis
To demonstrate the utility of our annotated network, we used our network in conjunction
with a directional enrichment analysis algorithm [2, 162] to identify drivers of differential
expressed genes. We utilized quaternaryProd, a gene set enrichment algorithm that
can take advantage of direction of regulation on causal biological interaction graphs to
identify regulators of differential gene expression. The quaternaryProd algorithm takes
a differential gene expression profile along with an annotated transcriptional regulatory
network, such as TRRUST or our ChIP-Network as input and outputs a set of candidate
differentially active protein regulators. The algorithm performs a directional enrichment
test based on the availability of information on the mode of regulation in the network.
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If no information on mode of regulation is available, the algorithm performs the Fisher’s
exact test or the enrichment scoring (ES) statistic, which is the standard for gene set
enrichment analysis. If the network if fully annotated, a generalization of the Fisher exact
test (correctness p-value) is performed. For networks with both signed and unsigned
edges, the algorithm performs Quaternary scoring (QS) statistic proposed by Fakhry et.
al [2].
The Network inputted to quaternaryProd is assumed to encapsulate knowledge of
TF-DNA interactions. The algorithm can use information on mode of regulation to
more accurately identify putative protein regulators. The ability of the algorithm to
identify regulators of differential gene expression relies heavily on the quality and the
coverage of the regulatory network on which the queries are performed. If the network
adequately encapsulates the interaction between TF and genes, the expectation is that
the quaternaryProd algorithm should be able to recover the true cause of the modulated
expression profile. To test the utility of our network, we used this algorithm along
with differential expression profiles from controlled over-expression experiments used in
the original study [116]. The over-expression experiments consist of differential gene
expression profile from a controlled in vitro E2F3 over expression [163] and c-Myc [163].
These over-expression experiments provide an ideal setting to test whether the network
provides adequate and accurate information for the algorithm to recover the perturbed
regulator or its closely related proteins. We inputted three networks into the algorithm
(1) the original TRUSST network, (2) annotated TRUSST network, and (3) annotated
TRRUST augmented with annotated ChIP-Atlas. By annotated TRRUST, we refer
to the TRRUST network where interaction with no reported mode of regulation were
annotated using our system.
Table 3.4: Directional enrichment analysis results on E2F3 expression signatures.
Differential gene expression analysis of these data sets resulted in 272, and 220 differ-
entially expressed genes respectively. Table 3.4 outlines the top 10 regulators predicted
by the algorithm on E2F3 differentially expressed genes sorted by the FDR corrected
quaternary p-values of the scoring scheme. For the E2F3 experiment, E2F1 is returned
as the top hypothesis regulator by the algorithm incorporating our annotated networks.
E2F1 and E2F3 are close family members and have a very similar role as transcription
factors that function to control the cell cycle and are similarly implicated in cancer [164].
It is interesting to note that original TRRUST database does not include enough infor-
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mation for algorithm to recover E2F1, however the signal strengthens when TRUSST is
annotated with our system and a much more significant p-value is obtained when TR-
RUST is augmented with annotated ChIP-Atlas. This shows that annotating ChIP-seq
data provides significant additional power to identify upstream regulators in conjunction
with freely available causal networks.
Application of the method to c-Myc differential expression profile shows the simi-
lar pattern. The annotated TRRUST with ChIP-Atlas recovered MAX as one of the
predicted regulators which were not identified using TRRUST and annotated TRRUST
networks ( p-value = 4.82E-03 and predicted as up-regulated). MAX was not identified
using two other networks with threshold 0.05 for p-values. It has been demonstrated
that oncogenic activity of c-Myc requires dimerization with MAX [165].
3.4 Conclusion
In this work we presented a fully automated text-mining system to extract and an-
notate causal regulatory interaction between transcription factors and genes from the
biomedical literature. As a starting point, our method uses putative TF-gene interac-
tions derived from high-throughput ChIP-seq or other experiments and seeks to collect
evidence and meta-data in the biomedical literature to support the interaction. It should
be noted that annotating a priori known interactions differs significantly in scope and
complexity from general text-mining approaches for biomedical relation extraction. The
later attempts to extract the causal relation from biomedical text directly, without prior
knowledge of the entities and the interaction, whereas in our method the relation is know
from biological experiments and curated databases a priori, thereby reducing the com-
plexity significantly. This approach bridges the gap between data-driven methods and
text-mining methods for constructing causal transcriptional gene regulatory networks
and overcomes some of the drawbacks of either approach. With the rapid increase in
high-throughput experiments and biomedical literature, hybrid method such as the one
proposed can make a significant impact in biological knowledge retrieval.
We used a gold-standard manually curated dataset and demonstrated that our ap-
proach can reliably identify the relevant literature and extract the correct interaction
and meta-data. We applied our method to high-throughput ChIP-seq data and pro-
vided literature support for 1,500 interactions. Our annotated ChIP-derived tran-
scriptional regulatory interaction can be used in conjunction with directional enrich-
ment methods that aim to identify regulators of differential gene expression. Moreover,
we use our system to annotate the interactions in the TRRUST database for which
more of regulation is not reported. Our system can also be used as a tool to mine
the literature for investigate interactions in newly performed ChIP-seq experiments,
where researchers are interested to investigate a specific interaction between a protein
and a gene. To facilitate usage, we implemented an HTTP REST server for users
to programmatically annotate gene regulatory networks using ModEx available via:
https://watson.math.umb.edu/modex/[type_query] (See section 3.5). The annotated
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The material in this chapter regarding cancer cross classification are mainly taken from
our publication in Nature communications, 2020[4]. The work in this chapter is a collab-
oration with the group of Prof. Jeffrey Chuang at the Jackson Laboratory for Genomic
Medicine and the groups of Prof. David Rimm and Dr. Emily Reisenbichler at Yale
University School of Medicine. The results regarding HER2 status classification and
treatment response prediction are currently under preparation to be submitted in a new
manuscript.
Cancer cells differ from normal cells in several aspects that allow them to become
massive and intrusive. Cancer cells spread widely without a halt in primary tissue
and can metastasize into nearby tissues. One of the lethal properties of cancer cells is
that they haven’t undergone programmed cell death also called as apoptosis. Apoptosis
is a natural mechanism in the body leading to characteristic cell changes and death
when it is required to be done. However, cancer cells are resistant to these signals
sent by the body to stop dividing [166]. The area that incorporates tumor cells is
called the tumor microenvironment. Cancer cells continue to divide and progress to the
blood vessels to supply nutrients, which is called angiogenesis [166]. Angiogenesis is a
biological process that new small blood vessels fork from existing blood vessels which is
a key element toward cancer progression and metastasis [167]. Furthermore, cancer cells
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present small molecules and signals to trick immune cells in the side of the body and
inactivate them. They further modify the nearby cellular microenvironments to make
them an antagonistic place for immune cells to work [168].
We are currently in the middle of a revolution in tissue imaging technology develop-
ment. Histology images provide a useful resource of data, respresenting the disease state
and characteristics since the imaging protocol preserves the underlying tissue struc-
ture [169]. Cancer disease characteristics as well as its associated microenvironment
can be deducted from histopathology images. It is stated that "The diagnosis from a
histopathology image remains the gold standard in diagnosing a significant number of
diseases including almost all types and subtypes of cancer" [170]. While these images
provide a multitude of information, they also pose several computational challenges.
The essential techniques for analyzing histological images are adopted from techniques
used to process cytology imagery [169]. For instance, nuclei sThe Cancer Genome Atlas
(TCGA)tructures of the cancerous cell are specific morphological features for quantita-
tive evaluation, commonly used by the experienced pathologists through general obser-
vation [169]. Analyzing the morphological features of histological images has become a
crucial step in most of the computational techniques handling these image data [169].
However, this field of research still has so many potentials and challenges due to various
imaging technologies being advanced.
Histopathological images are a crucial data type for diagnosis of cancer malignancy
and selecting treatment [171], providing a great resource for understanding cancer biol-
ogy. However, manual analysis of whole slide images (WSIs) is labor-intensive [172] and
can vary by observer [173], making it difficult to scale such approaches for discovery-
oriented analysis of large image collections. Image datasets for hematoxylin and eosin
(H&E), immunohistochemistry (IHC), and spatial -omic imaging technologies are rapidly
growing [174]. Improved computational approaches for analyzing cancer images would
therefore be valuable, not only for traditional tasks such as histopathological classifi-
cation and cell segmentation (Cooper et al. 2018), but also for novel questions such
as the de novo discovery of spatial patterns that distinguish cancer types. The search
for recurrent spatial patterns is analogous to the search for common driver mutations
or expression signatures based on cancer sequencing, yet this paradigm has been little
explored for cancer image data.
In the last few years, there have been major advances in supervised and unsupervised
learning in computational image analysis and classification [175], providing opportunities
for application to tumor histopathology. Manual analysis involves assessments of features
such as cellular morphology, nuclear structure, or tissue architecture, and such pre-
specified image features have been inputted into support vector machines or random
forests for tumor subtype classification and survival outcome analysis, e.g. [176, 177].
However, pre-specified features may not generalize well across tumor types, so recent
studies have focused on fully-automated approaches using convolutional neural networks
(CNNs), bypassing the feature specification step. The general idea is to apply specific
CNN architecture to WSIs to learn perdicitice features associated with the output task
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Figure 4.1: Basic workflow of CNN application in WSIs. Patches are sampled from WSIs
and used to train a CNN to predict outcome. The CNN consists of (i) convolutional layers
that learn visual patterns related to outcome, using convolution and pooling operations,
(ii) fully connected layers that provide additional nonlinear transformations of extracted
image features, and (iii) a softmax layer that predict the outcome based on the features.
Predictions are compared with patient outcomes to adaptively train the network weights
that interconnect the layers. Figure from [178].
such as cancer/normal prediction or subtype classification. Figure 4.1 illustrates the
basic workflow of CNN application in WSIs analysis.
For example, Schaumberg et. al., trained ResNet-50 CNNs to predict SPOP mu-
tations using WSIs from 177 prostate cancer patients [179], achieving AUC = 0.74 in
cross validation and AUC = 0.64 on an independent set. Yu et al., utilized CNN ar-
chitectures including AlexNet, GoogLeNet, VGGNet-16, and the ResNet-50 to identify
transcriptomic subtypes of lung adenocarcinoma (LUAD) and squamous cell carcinoma
(LUSC) [180]. They were able to classify LUAD vs. LUSC (AUC of 0.88-0.93), as well
as each vs. adjacent benign tissues with higher accuracy. Moreover, they were able
to predict the TCGA transcriptomic classical, basal, secretory, and primitive subtypes
of LUAD [181] with AUCs 0.77-0.89, and similar subtype classifications have been re-
ported in breast. Recently, Coudray et al. [182] proposed a CNN based on Inception
v3 architecture to classify WSIs in LUAD and LUSC, achieving an AUC of 0.99 in
tumor/normal classification. Further, their models were able to predict mutations in
10 genes in LUAD with AUCs 0.64-0.86, and subsequently mutations in BRAF (AUC
∼ 0.75) or NRAS (AUC ∼ 0.77) melanomas [183]. Other groups have used CNNs to
distinguish tumors with high or low mutation burden [184]. These advances highlight
the potential of CNNs in computer assisted analysis of WSIs. Recently, several stud-
ies presented pan-cancer within and cross analysis to study shared spatial behaviors in
histological images [185, 186, 4, 187].
Many critical questions still remain. For example, prior studies have focused on
individual cancer types, but there has been little investigation of how neural networks
trained on one cancer type perform on other cancer types, which could provide important
biological insights. As an analogy, comparisons of sequences from different cancers have
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revealed common driver mutations [188, 189], e.g. both breast and gastric cancers have
frequent HER2 amplifications, and both are susceptible to treatment by trastuzumab
[190, 191]. Such analysis is in a rudimentary state for image data, as it remains unclear
how commonly spatial behaviors are shared between cancer types. A second important
question is the impact of transfer learning on cancer image analysis, which has been used
in studies such as [182]. Transfer learning is used to pre-train neural networks using
existing image compilations. However, standard compilations are not histological, and
it is unclear how this affects cancer studies. A third key topic is to clarify the features
that impact prediction accuracy. For example, recurrent neural network approaches
[192] have been shown to distinguish prostate, skin and breast cancers at the slide level,
but the relevant spatial features are not well understood. Determination of predictive
features is affected not only by the underlying biology, but also by availability of spatial
annotations and appropriate computational techniques.
To investigate these questions, here we analyze frozen or FFPE whole-slide H&E
images from cancer types from The Cancer Genome Atlas (TCGA), a resource with
centralized rules for image collection, sequencing and sample processing. We have uti-
lized an image processing and convolutional neural network software that can be broadly
applied across tumor types to enable cross-tissue analyses. Using these techniques, first,
we show that this CNN architecture can distinguish tumor/normal, cancer subtypes and
frequent gene mutations in lung tissue. Next, we investigate driver effects by determin-
ing how cancers with the TP53 mutation can be cross-classified across tissues, including
a comparison of transfer learning vs. full CNN training. Finally, we used CNN model to
predict HER2 positive/negative breast cancer annotated by senior pathologists in Yale
school of medicine. Our studies demonstrate that cross-comparison of CNN classifiers
is a powerful approach for discovering tumor, tumor subtypes, mutational status, and
shared biology within cancer images.
4.2 Materials and Methods
4.2.1 Datasets
The Cancer Genome Atlas (TCGA)
The Cancer Genome Atlas (TCGA) is the most comprehensive source of genomic
data, which is coordinated globally to boost our understanding of the molecular ba-
sis of cancer [193]. It incorporates around 200 cancer types along with the molecular
signature of the genome. We used NCI Genomic Data Commons [194] , offering an
interactive and user-friendly platform for accessing the cancer-related data and visual-
izing them [182]. We downloaded all of the freely available slides corresponding to Lung
Adenocarcinoma and Squamous Cell Carcinoma (TCGA-LUAD/LUSC), Breast Invasive
Carcinoma (TCGA-BRCA), Colon Adenocarcinoma (TCGA-COAD), Stomach Adeno-
carcinoma (TCGA-STAD), and Bladder Carcinoma (TCGA-BLCA) from this database.
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First, we studied automatic classification of 459 and 1,175 slides corresponding to
Normal and Primary Tumor of Lung cancer respectively. Next, we applied CNN to
classify two main Non-Small Cell Lung Cancer (NSCLC) subtypes including 567 and
608 slides of LUAD and LUSC groups. Furthermore, we utilized a modified version of
the inception v3 [182] to predict mutational status from histopathology images through
a multitask classification scheme. We only focused on LUAD samples to perform mu-
tational status classification, in which we considered a binary label 0 or 1 for each gene
based on whether it is mutant or wild-type in the sample, in order to generate a bi-
nary vector for the multi-label classification. For this purpose, gene mutation data for
matched patient samples were downloaded from TCGA. To make sure the training and
test sets contained enough images from the mutated genes, we only selected those which
were mutated in at least 10% of the available tumors. As a result, top 10 frequent genes
were selected to be considered in classification task. Note that we only included tiles
that are predicted as LUAD tiles in our subtype classification task (LUAD vs LUSC
vs Normal) in order to avoid biasing the network to learn LUAD-specific versus LUSC-
specific mutations and to focus instead on distinguishing mutations relying exclusively
on LUAD tiles. 382 LUAD slides along with their mutational status were used for this
task.
Finally, we used a cross-classification scheme to test the hypothesis that different
tumor types share CNN-detectable morphological features related to their mutational
status. We selected flash frozen WSIs of BRCA, LUAD, STAD, COAD, and BLCA
cancer types. We only investiagted the mutational status of TP53 gene due to its high
mutation frequency [195, 196], providing sufficient testing and training sets for cross-
classification analysis. Impactful TP53 mutations were determined using masked somatic
mutations maf files called by MuTect2 [197]. We first considered all called mutations
categorized as MODERATE/HIGH (by VEP software [198]) in the IMPACT column. If
the gene had at least one such mutation in the sample, it was counted as mutated and
was considered as wild-type otherwise. Table 4.1 shows the number of wild type and
mutated slides in each cancer type. For cross classification, the model was trained on
the entire training set and predictions were made on the entire test set. Note that for
all of the aformentioned analysis, we devoted 70% and 30% of the data to training and
test set respectively.
Annotated breast cancer slides with HER2 status
We analyzed 188 H&E slides generated at Yale School of Medicine and were annotated
with Region of Interests (ROIs) associated to HER2 positive and negative tumor micro
environments, by a senior pathologist. The slides were scanned at Yale Pathology Tissue
Services and were undergone a slide quality check before they go into the scanner, and
also broken slides, slides with broken coverslips and slides with no/minimal tissue, were
also removed. The tissue samples were scanned using Vectra Polaris by Perkin-Elmer
scanner using bright filed whole slides scanning at 20×magnification, at Brady Memorial
Laboratory Rimm’s lab. The scope were booked in advanced prior scanning and a
period of 1 week has been allotted for scanning process. The annotations were marked
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BRCA 647 338 699 438,813 286 198,580
LUAD 295 270 396 452,419 169 193,245
STAD 237 200 306 428,872 131 176,059
BLCA 217 194 276 125,003 112 60,061
COAD 217 214 283 150,881 115 60,312
Figure 4.2: Number of training and testing slides and corresponding tiles for HER2
breast cancer analysis.
tumor boundaries and annotated by Aperio ImageScope software [199]. The annotations
was exported from the Aperio software in The Extensible Markup Language (XML)
format, including X and Y coordination corresponding to the annotated regions. We
used these coordinations for each slide image to tile these regions separately from the
rest of the image, labeled as HER2+ or HER2- class. Figure 4.2 shows number of slides
and corresponding tiles for training and testing of the model. We used 70% and 30% of
the slides for training and testing the CNN.
4.2.2 Deep Learning Architecture
Data cleaning, tiling and balancing
The first step of the analysis is data cleaning and tiling. SVS slides were acquired from
the databases and tiled into non-overlapping patches of 512× 512 pixels in 20× magni-
fication. This step removed background as in [182] and excluded regions without tissue
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Figure 4.3: Five different data augmentation ways incorporated in our preprocessing
step.
and also limits regions with excess fat. Tiles were shuffled and assigned to TFRecords
in groups of 1024. The TFRecord file format is a simple format for storing a sequence of
binary records. TFRecord is TensorFlow as native storage format and enables high data
throughput which results in a more efficient model training pipeline. TFRecords were
then used as input to the CNN model for training or testing. To mitigate the effects of
label imbalance in our classification tasks, undersampling was performed during train-
ing by rejecting inputs from the larger class according to class imbalances, such that, on
average, the CNN receives equal number of tiles in each class as input.
Data Augmentation
Data augmentation is an important step employed for reducing CNN generalization error
by generating realistic variations of the training data. In other word, data augmentation
is a way to address batch effects as a confounding factor to limit the power of model.
The basic idea is to create artificial variations of training data to mimic the appear-
ance of future test samples. The main approach used for this purpose is morphological
transformation, which augmentation
starts from simple methods like image rotations, mirroring, and scaling; to more so-
phisticated methods like elastic deformation [200], additive Gaussian noise, and Gaussian
blurring [201]. Here, we used 90, 180, and 270 degree rotations and filliping horizontally
and vertically. Figure 4.3 illustrates 5 different data augmentation ways incorporated in
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Figure 4.4: Deep Convolutional Gaussian Mixture Model for Stain-Color Normalization
in Histopathological H&E Images.
this section.
Color Normalization
The nucleus and cytoplasm are differentiated in histological tissue images through hema-
toxylin and eosin staining [202]. In such a colorization procedure, several confounding
factors may be involved, making it hard to standardize image coloring between different
medical centers or even within the same laboratory samples at various trials or time peri-
ods [202]. The specimen sample preparation protocol, staining protocols, scanning, and
imaging device characteristics are some sources of such variations, leading to color and
intensity variations in histopathological images. There are two main approaches to ad-
dress the sources of color variations in staining histopathological images [202]. The first
approach ignores the color information in images by transforming them into grayscales
such as texture [203] and wavelet [204] transformations. However, ignoring the color
information for bypassing the problem can pose a confounding factor in signal extrac-
tion leading to poor medical diagnostics in the pathological application. Therefore, stain
color normalization is broadly studied and used in histopathological image analysis using
machine learning algorithms [205, 206, 207].
We used a deep generative model based on CNN for fully unsupervised learning of
stain-color normalization [202]. The method is fully unsupervised and does not need
any labels or prior assumptions on the H&E image contents. In this method, it is stated
that: "Three essential properties are considered to adapt conventional deep generative
models to stain-color normalization: 1. The image structures must be preserved after
color conversion, and only the chromatic information can be subject to change. 2. The
model does not need any labels or any assumptions about the data and should be fully
unsupervised. 3. The model should learn the color transformation between any two
image pairs" [202]. The model doesn’t have to convert the input images’ color to only
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Figure 4.5: Classification pipeline used for histopathology image analysis
a predefined reference image. The model can be defined as a generative models that
by applying on input image can create different color copies of input image to somehow
the converted image contain specific chromatic distribution. The method contains two
stage: (1) Fitting a Gaussian mixture model (GMM) by considering the shape and
appearance of image content structures. To do so, the visual representation and modeling
of convolutional neural networks (CNNs) are exploited. (2) transforming the estimated
distribution to any arbitrary distribution computed from a secondary (template) image.
Figure 4.4 shows an example of stain-color normalization of randomly selected tiles before
and after transformation.
One of the shortcoming of this approach is that its current implementation only
supports one batch size, which put a lot of computational workload when we are deal-
ing with massive amount of images to train the model. This situation brought us into
memory limitation errors when we were trying to train the model using the entire tiles
corresponding to the slides. In order to overcome this issue, we randomly selected 100
tiles from each image to train the model with relatively smaller training set. Note that
this approach may not represents the entire stain color distribution of the training data.
Furthermore, the training step doesn’t limit to the number of iteration set on its config-
uration file. we set the number of iteration to 100,000 that the training process wasn’t
converged through this number of iterations. Therefore, we used the saved checkpoint
corresponding to the 100,000 iteration.
CNN Architecture and Training
We used Google inception v3-based architecture [182] for tumor/normal, subtype and
mutational status classification of H&E slides. The inception v3 architecture was fully
trained for TCGA dataset. However, we used both fully training and Transfer learning
for Yale HER2 breast cancer samples.
In transfer learning, we initialized our network parameters to the best parameter set
that was achieved on ImageNet competition [208] . We then fine-tuned the parameters
of the last layer of the network on our data via back propagation. The loss function
was defined as the cross entropy between predicted probability and the true class labels,
and we used RMSProp69 optimization, with learning rate of 0.1, weight decay of 0.9,
momentum of 0.9, and epsilon of 1.0 method for training the weights. This strategy was
tested for the binary classification of LUAD versus LUSC.
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In fully training, similar to transfer learning, we used back-propagation, cross entropy
loss, and the RMSProp optimization method as well as the same hyperparameters as
the transfer-learning case for the training. In this approach, instead of only optimizing
the weights of the fully connected layer, we also optimized the parameters of previous
layers, including all of the convolution filters of all layers. The training jobs were run
for 500,000 iterations. We computed the cross-entropy loss function on the train set.
The model outputs for tiles were used to produce slide level prediction by averaging
probabilities. Due to significant additional compute costs we did not optimize on hyper
parameters, e.g. number of epochs or learning rate, instead using common values for
similar image classification problems. Figure 4.5 represents the classification pipeline
used for analyzing H&E slides.
Computational Configuration
All analysis was performed in Python. Neural network codes were from [182]. Im-
ages were analyzed using OpenSlide [209]. Classification metrics were calculated using
Scikit-learn [210]. Confidence Intervals at 95% were estimated by 1,000 iterations of the
bootstrap method [211].All of the computational tasks were performed on linux High
performance computing clusters with following specification: 8 CPUs, RAM: 64 GB,
and Tesla V100 GPUs, 256 GB RAM. Furthermore, The GPU-supported TensorFlow
needed CUDA 8.0 Toolkit and cuDNN v5.1. All GPU settings and details were obtained
from TensorFlow and TF-slim documentations and NVIDIA GPUs support.
4.3 Results
4.3.1 Tumor/Normal Classification
We used a CNN to classify slides from TCGA Lung tissue by tumor/normal status, using
a neural network that feeds the training tile set into Inception v3 architecture for fully
training of model. Due to insufficient FFPE normal WSIs in TCGA, for this task we
only used flash frozen samples. We trained this model separately on slides from TCGA
lung cancer type having numbers of slides. 70% of the slides were randomly assigned
to the training set and the rest were assigned to the test set. To address the data
imbalance problem, the majority class was undersampled to match the minority class.
Figure 4.6a shows tumor/normal classification performance of the CNN model. We
estimated the output prediction of model for slide level by averaging the probabilities of
the entire tiles. We selected 0.5 as the threshold to assign either a tile or slide to output
classes. Previous studies yielded 0.85 AUC by the feature-based approach [212], and
0.94 AUC performance by plasma DNA analysis [213] incorporating molecular profiling
data. Our result reproduced same performance that was reported by Coudray et. al.
[182] that we obtained our core analysis pipeline from (Figure 4.6b). We also calculated
the predicted class sing percentage of classified tiles to each class, instead of averaging
the probabilities in each class. In all of the experiments, averaging technique acquired
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Figure 4.6: Tumor/Normal classification performance of TCGA lung tissue slides. Panel
4.5a shows the ROC curve of the inception v3 model for both slide level and tile level
average probabilities.
higher AUC performance. Similar pattern observed when we calculated slide-level AUC
over tile-level AUC.
4.3.2 Cancer Subtypes Classification
Next, we tested the performance of the CNN on the more challenging task of distin-
guishing two very important non-small cell lung cancer: Lung Adenocarcinoma (LUAD)
and Lung Squamous Cell Carcinoma (LUSC). For this purpose, we fully trained an
inception-v3 by training and testing the network on a direct three-way classification into
the three types of images (normal, LUAD, LUSC). The output layer of the network is
a softmax layer that estimate a joint probability for each class which sum up to 1. The
highest probability is the winner class. Figure 4.7 exhibits the slide-level AUC values
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Figure 4.7: Lung cancer subtypes classification AUCs. AUC statistics were calculated
using a multiclass classification task when the aggregation is done by averaging the
per-tile probabilities.
for the three-way classification task. This experiment led to similar results as Coudray
et. al. [182] for lung cancer subtypes classification and also significant improvements
compared to previous studies exploited various molecular-based techniques.
4.3.3 Gene Mutational Status Prediction
Next, we investigate wether CNN model can predict mutational status using images as
the only input. For this purpose, we only included LUAD slides and also focused on
tiles classified as LUAD by the previous three-way classification model were used for this
task in order to avoid biasing the network to learn LUAD-specific versus LUSC-specific
mutations and to focus instead on distinguishing mutations relying exclusively on LUAD
tiles. We downloaded gene mutation data for matched patients from TCGA database.
For this task, we fully trained a multi-label classifier to predict the mutational status
of top 10 frequent gene mutations in LUAD. Our resulted AUC values are presented
in Figure 4.8 along with reported AUCs by [182]. Our results are comparable to the
previously reported performances, but we were not able to reproduce similar AUC values.
The results show that five frequently mutated genes seem predictable using CNN model;
AUC values for serine/threonine protein kinase 11 (STK11), EGFR, SET binding protein
1 (SETBP1), KRAS and TP53 were between 0.70 and 0.856.
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Figure 4.8: Gene mutation prediction from histopathology slides.
4.3.4 TP53 Mutation Classification
To investigate how images can be used to distinguish cancer drivers, we tested the
accuracy of CNNs for classifying TP53 mutation status in 5 TCGA cancer types, namely
Breast Invasive Carcinoma (BRCA), LUAD, Stomach Adenocarcinoa (STAD), Colon
Adenocarcinoma (COAD) and Bladder Carcinoma (BLCA) . We chose these due to
their high TP53 mutation frequency, providing sufficient testing and training sets for
cross-classification analysis. Using transfer learning, we obtained moderate to low AUCs
for TP53 mutant/wildtype classification (0.66 for BRCA, 0.64 for LUAD, 0.56 for STAD,
0.56 for COAD, and 0.61 for BLCA). Due to this weak performance we switched to a more
computationally intensive approach in which we fully trained all parameters of the neural
networks based on an architecture we descrived before, with under-sampling to address
data imbalance and a 70/30 ratio of slides for training and testing. Figures 4.9a and 4.9b
show heatmaps of AUC for the per-tile and per-slide classification results, respectively.
Self-cohort predictions (diagonal values) have AUC values ranging from 0.65-0.80 for per-
slide and 0.63-0.78 for per-tile evaluations. Stomach adenocarcinoma (slide AUC=0.65)
was notably more difficult to predict than lung adenocarcinoma (slide AUC=0.80), for
which we found AUC values comparable to the AUC=0.76 LUAD results reported by
(Coudray et al. 2018). This LUAD fully-trained network (AUC=0.76) outperformed
the transfer learning for the same data (AUC = 0.64).
We also tested the ability of the TP53 CNNs to cross-predict across cancer types.
Cross-predictions yielded AUC values with a comparable range as the self-cohort anal-
yses (AUCs 0.62-0.72 for slides; 0.60-0.70 for tiles), though self-cohort analyses were
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Figure 4.9: Classification of TP53 mutation status for TCGA cancer types BRCA,
LUAD, BLCA, COAD and STAD. Cross- and self- classification AUC values from bal-
anced deep learning models (with 95% CIs) are given (a) per-slide and (b) and per-tile.
slightly more accurate. These AUC values are not sufficient for practical use, though
the positive cross-classification results suggest that it might be possible to combine
datasets to increase accuracy. Colon adenocarcinoma AUC values tended to be low as
both a test and train set, suggesting TP53 creates a different morphology in this tissue
type. Overall, the positive cross-classifiabilities support the existence of shared TP53
morphological features across tissues. Figure 4.10 shows TP53 mutational heatmaps of
one LUAD slide known to be mutant and one LUAD slide known to be wildtype from
sequencing data. We compared the LUAD- and BRCA-trained deep learning models
on these slides, as those two models provided the highest AUC values in our cross-
classification experiments. Prediction maps for tumor/normal status (second row) and
TP53 mutational status (third row) are shown for both samples. Both tumor/normal
models correctly predicted the majority of tiles in each sample as cancer. Analogously,
the BRCA-trained TP53 mutation status model predicts patterns similar to the LUAD-
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Figure 4.10: TP53 genotype heatmaps based on predicted probabilities using our deep
learning model. The first row shows two LUAD H&E slides with TP53 mutant (left
panel) and wild type (right panel). The second row shows prediction maps for these two
slides using tumor/normal classifiers trained on BRCA and LUAD samples. Both models
successfully classify samples as cancer and predict similar heatmaps. The third row shows
prediction maps for these slides using TP53 mutation classifiers trained on BRCA and
LUAD. The BRCA-trained and LUAD-trained heatmaps are similar, suggesting that
there are spatial features for TP53 mutation that are robust across tumor types.
trained model. Importantly, the tumor/normal and TP53mut/wt classifiers highlight
different regions, indicating these classifiers are utilizing distinct spatial features. A
caveat to these analyses, however, is that the spatial variation within heatmaps may
reflect TP53mut-associated microenvironmental features rather than genetic variation
among cancer cells.
To determine whether the CNN model uses information more sophisticated than
tumor purity and stage to predict TP53 mutational status, we compared its performance
to a random forest model. The random forest model was trained to predict TP53 status
using only tumor purity and stage for each of the five cancer sets. Training was performed
at slide level. The corresponding AUC self- and cross-classification values are shown in
Figure 4.11, with the CNN-based AUCs shown for comparison. The AUC values from
the Random Forest model are lower than the AUCs from the CNN model in all cases.
Sample sizes are provided in Table 4.1.
We considered classification performance when using an additional minimum thresh-
old for TP53 mutation frequency which should favor cases where the mutation is ubiq-
uitous throughout the tumor. We tested our trained CNN model within each cancer
type, with a requirement of high minor allele frequency (MAF > 0.25). Our model has
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Figure 4.11: TP53 mutational classification performance comparison between CNN
model and Random Forest model trained on tumor purity and stage. The CNNs achieved
a higher AUC compared with a random forest using tumor purity and stage for TP53
mutation prediction, suggesting the CNNs use more sophisticated morphological features
in their predictions.
increased AUC on such cases in all cancer types. We also analyzed samples based on a
strict IMPACT metric (requiring IMPACT=HIGH). Truncating the sample by this IM-
PACT constraint does not lead to a systematic improvement in AUC, as different cancer
types show varying effects (Figure 4.12). Test set is similar in size to the set described in
Table 4.1, except positive class labels are now determined using additional constraints.
Therefore, We observed that CNNs were able to more accurately identify tumors with
TP53 mutations when the allele frequency of the mutation was higher, suggesting that
prediction is easier when the tumor is more homogeneous.
We next performed a tile-level cross-classification analysis as a function of test set.
For most test cancer types, we observed little correlation when comparing networks
trained on cancers and applied to test cancer. Therefore, we focused on cases where
c is the same as b. Figure 4.13 plots the correlations of TP53 mutation probability
logits across cancer pairs, where each row denotes the cancer type the first CNN is
trained on, and each column is both the test tissue and the second CNN training tissue.
In these cases the correlation coefficients were generally positive and met statistical
significance though with moderate magnitude. All correlations were significant except
for the BRCA TP53 classifier applied to LUAD tumors (t-test on Fisher z-transformed
correlation coefficients, FDR 5%). Notably, classifiers based on LUAD, BRCA, and
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Figure 4.12: TP53 mutational classification performance as a function of allele frequency
and mutational impact.
COAD, worked well on BLCA, BLCA, and COAD tumors, respectively. BLCA and
LUAD are the two test cancers with the largest correlations (column average). LUAD
and COAD are the two training cancers with the largest correlations (row average). The
high row and column averages for LUAD indicate it is canonical both as a test and a
training set. Interestingly, the correlations of Figure 9 are not symmetric. For example,
the network trained on LUAD achieves a correlation of 0.34 on BLCA, while the network
trained on BLCA has a correlation of 0.04 when tested on LUAD.
4.3.5 Breast Cancer HER2 Status Prediction
In this section, we presented another problem that we addressed using similar method-
ology to classify breast cancer HER2 status as well as response to treatment. A lot
of work has been done in breast cancer prediction and classification. The Camelyon
2016 and Camelyon 2017 Challenges [214] aimed to promote algorithm development for
detection of breast cancer on H&E and breast cancer metastasis from H&E of lymph
nodes. The TUPAC16 challenge benchmarked the prediction of proliferation score based
on mitosis counting (H&E) and prediction of proliferation score based on molecular data
(e.g. RNA Expression). The use of H&E slides and Deep learning ushers in a new era
of low cost diagnostic testing and leaving out applying more expensive tests on unequiv-
ocal cases. The impact of this is immense and to out knowledge such a project is not
being undertaken by another group in the field. Here, we used inception-v3 model to
predict breast cancer Her2 status meaning whether the tumor is Her2 positive (Her2+)
or negative (Her2-) status which has a potential impact on diagnostic and its relevant
cost. 188 annotated H&E slides have been analyzed here as we described in section 4.2.1 .
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Figure 4.13: Tile-level cross classification correlations for TP53 mutational status. Row
labels denote the cancer type used to train the first TP53 mutation classifier. Column
labels denote both the test tissue and the tissue of the second TP53 classifier. Heatmap
values indicate correlation coefficients of mutation probability logits between the two
classifiers on the test tissue. Numbers at the bottom and right show column and row
averages, respectively, with diagonal values excluded.
Prediction of Unannotated Slides
We first investigated whether our model is able to predict the HER2 status using
unannotated slides. For this purpose, we ignored the ROIs and tiled the entire slides in
20×magnification and 512×512 non-overlapping patch sizes. Each tile from a slides, was
assigned a label whether Her2+ or Her2- according to its slide-level label. The inception
v3 was both trained using both fully-training and transfer learning on randomly assigned
of 70% and tested on 30% of the slides. Note that we balanced the training set by un-
dersampling the larger class to reach to equal size in both classes. Figure 4.14 shows the
slide-level and tile-level of fully-training and transfer learning approaches which resulted
in similar performances. Furthermore, there is a significant differences between tile-level
and slide-level AUCs. We further provided several example of HER2+/- slides , together
with heatmaps generated by our pipeline, in which the color of each tile corresponds to
the predicted class, and the color shade is proportional to the classification probability.
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Figure 4.14: HER2 status prediction performances using fully training and transfer
learning.
Prediction of Annotated Slides
Next, we took annotated regions which are bounding the tumor micro-environment.
The goal is to discriminate tumor region with exterior region including normal, stromal
and mixed cells, in which the CNN could learn more specific features related to HER2+/-
tumor status. For this analysis, each slide was masked, tiled and categorized into Tumor
and Other regions (exterior cellular environment). Therefore, we considered 3 classes in-
cluding HER2+, HER2- and other for the classification task. We labeled each tile based
on the annotations and randomly assigned 70% of the slides for training and 30% for
testing the inception v3 classifier. First, we trained a two-class classifier for HER2+/-
prediction by calculating the average of the output probabilities for HER2+ and HER2-
classes and consider 0.5 threshold to classify the slide ( excluding "Other" class leading
to a binary classification ). Figure 4.15 presents the AUC values of the CNN classifier
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Figure 4.15: HHER2 status prediction results of annotated slides excluding other class
for fully training and transfer learning.
using both fully-training and transfer learning approaches. Although the values from
both approaches are almost similar, taking the annotations into account improved the
performance of the models significantly compared to unannotated models. Finally, we
aimed to include a class named “other” and train models in a three-class classification
scheme. Our goal was to see whether the three-way classification can improve the tile-
level accuracy , and also to illustrate the prediction heatmaps highlighting HER2+/-
regions distinguished from normal region. Figure 4.16 exhibits the classification AUCs
for trained models. The results show a significant increase in the model’s tile-level accu-
racy when we included all three classes into the classification task. similar to previous
results, transfer learning and fully-training achieved almost comparable accuracy. We
also investigated whether a smaller tile size can improve the resolution and performance
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Figure 4.16: Three-way HER2 status classification results for fully-training with 512 tile
size and transfer learning including both 512 and 256 tile sizes.
of the model. For this purpose, we trained the inception v3 using the transfer learning
approach on the same train and test sets tiles in 256×256 pixels. It reduces the accuracy
of the model pointing to the fact that high-resolution tiles might be a confounding factor
for the model.
Model validation using external dataset
We aimed to validate the HER2 status predictive model using an external test set to
have more stringent validation regarding the performance of the model. TCGA-BRCA
cohort was download from GDC data portal along with corresponding Her2 status for
each patient. The dataset consists of 569 HER2-negative and 99 HER2-positive FFPE
samples. We performed a quality assessment step over the samples to exclude samples
with poor scanning and staining quality. As a result, we filtered in 197 samples including
92 and 95 HER2-negative and her2-positive samples respectively for further analysis.
Background noise was removed from the slides which were tiled into 176,399 and 193,546
tiles with 512×512 pixels. Next, we performed a stain-color normalization using the deep
generative model [202] explained in section 4.2.2, by considering Yale’s dataset as the
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Figure 4.17: Three-way HER2 status classification results for fully-training with 512 tile
size and transfer learning including both 512 and 256 tile sizes.
template dataset and TCGA-BRCA as the source dataset to be normalized. We created
a test TFRecord for each test slide and use them to validate our model. The test slides
were annotated with tumor regions by the pathologist team at Yale’s university to have
ground truth in our validation. We test our model using each test slide and calculate the
AUC both per-slide and per-tile approaches. the AUC of the model performances are
0.81 ( CI:[0.73 0.84] ) per-slide and 0.65 ( CI:[0.54 0.69] ) per-tile. We further generate
prediction heatmaps to compare the performance of the model with annotated slides as
ground truth. Figure 4.18 shows two samples of predicted heatmaps and corresponding
annotated slide by a pathologist. The results shows our deep learning assessment was
able to identified spatial and morphological features resulted in relatively robust and
efficient predictive model.
68
4.3.6 Prediction of HER2-positive treatment outcome
One of the crucial question that we aimed to answer was how much the morphological
features would be correlated with treatment outcome prediction. This is a challeng-
ing question to tackle, even when using different modalities of relevant biological data.
We aimed to tackle this challenge using our deep learning methodology to see if the
model is able to find spatial features associated with the treatment outcome. To in-
vestigate, our pathologist team at Yale university generated pre-treatment H&E slides
for HER2-positive patients post-treating with Trastuzumab (Herceptin) chemotherapy.
HER2-positive is an aggressive form of breast cancer that grows and spreads rapidly and
incorporates 20% of patients with breast cancer. The main contribution of this drug as a
small molecule is to bind to the HER2 (receptor) and block it to avoid the proliferation
of cancer cells [215]. We labeled the samples according to the molecular data (HER2
marker during Immunohistochemistry (IHC) experiment) produced by experimental pro-
cedure after treatment to see whether the tumor sample is responder ( residual size of
tumor >0 ) or non-responder ( residual size of tumor=0 ). Next, the slides were anno-
tated to circle tumor micro-environments in each of the pre-treated slides. The dataset
generated for this experiment incorporates 49 non-responder and 36 responder slides.
We applied preprocessing step including removing background noise, tiling and sorting
into 70% training set and 30% test set, data augmentation and balancing to responder
tiles to generate train and test TFRecords.
We trained and tested the models using two scenarios: 1- annotated model which is
using only annotated regions with tumor sections labeled as responder or non-responder,
2-unannotated model which is using the entire slide labeled them as responder or non-
responder. Our model achieved 0.68 AUC performance for slide-level prediction and
0.63 AUC values fro tile-level predictions for unannotated model. Also, Our model
achieved 0.80 AUC performance for slide-level prediction and 0.73 AUC value for tile-
level predictions for annotated model. These results support the hypothesis that there
exist image-based biomarkers to predict treatment response using deep learning assess-
ment. Our model was able to predict the treatment outcome with 80% AUC using
morphological features annotated by a pathologist. Furthermore, we performed a 5-fold
cross-validation to have more stringent validation due to the small sample size in this
task. The 5fold cross-validation returned mean value 0.81 slide-level and 0.75 tile-level
AUCs, showing similar performance to the previous validation. The reported results
confirm that deep learning model is able to identify morphological variations associated
to treatment outcome and show potentials to expand it to other treatment outcome
prediction tasks.
4.4 Conclusion and Discussion
In this chapter, we have presented a versatile CNN-based framework for the cancer
analysis of histology images. Using this framework, we were able to train extremely
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Figure 4.18: Examples of prediction heatmaps for TCGA-BRCA test data.
accurate slide-based tumor/normal classifiers in lung cancer type, and we also were able
to classify subtypes and TP53 mutation status with significant though less extreme
accuracy. Critically, these studies enabled us to compare classifier outputs as a function
of training tissue, test tissue, and neural network architecture. Cross-classification for
tumor/normal status was successful in lung cancer, despite the variations in native tissue
morphology and fat content. These studies showed that tumor images have a robust
intraslide structure that can be consistently identified across CNN classifiers.
In the second part of this chapter, we introduced a deep learning assessment to clas-
sify HER2 status in breast cancer tumor and its treatment outcome using Trastuzumab
chemotherapy. our model was able to train and tes accurately using annotated slides to
predict HER2-positive and HER2-negative tumor micro-environment and highly agreed
with manually-annotated slides by pathologists. We further showed that similar strat-
egy can be applied for treatment outcome prediction and can relatively compete with
expensive molecular screenings.
Self- and cross-comparisons of classifiers can highlight robust spatial structures within
tumor images, but interpretation remains a major challenge. Neural networks provide
only indirect information about the features responsible for such structures, and expert
manual pathological analysis of such cases will be essential. Manual analyses may also
clarify the identity of predictive features whose existence is supported by CNNs. it will
be also important to analyze regions with spatial diversity rather than only regions of
high purity, which has been the focus of some recent works. Finally, to improve tile-
level understanding using these approaches, further fine-grained pathological annotations
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with concomitant hypothesis development from the community are vital, e.g., through








This chapter presents materials that are still work in progress. We are currently extend-
ing the tests and are working to prepare a publication based on these material in near
future.
Each tissue is a construct of different types of cells, which work and interact together
to function properly. The cellular microenvironment mediates each cell’s operation by
sending and receiving signals. Single-cell RNA-seq (scRNA-seq) technologies are rev-
olutionary approaches that have been incorporated in many cutting-edge discoveries
during the last decade. The majority of studies were performed toward understanding
the combination of the cellular population within a tissue [216].
However, several studies have shown that gene expression pattern in cells has a
tissue-specific pattern, reflecting the fact that tissue environment plays a prominent role
in mediating cell states [216, 148, 217]. The scRNA-Seq technologies cannot provide
spatial information for studying the tissue’s structural organization and the interaction
between cell types in the cellular microenvironment [216]. Recent technologies have
been developed to capture cellular features such as transcriptomic and proteomic char-
acteristics in a spatially-resolved manner attributed to single cells and their structural
location within the tissue [216]. These technologies have discovered valuable morpho-
logical attributes that previously could only be identified through indirect approaches
[218]. They collect a wide range of resolution and throughput. Spatially-resolved tran-
scriptomic (ST) approaches can cover and characterize the transcriptomic landscape of
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Figure 5.1: Spatially resolved transcriptomics methods overview. Figure from [219].
a: During the experimental procedure, thin tissue section are placed on a specially
barcoded array, either densely packed beads or printed spots. There is an available
option to stack multiple sections to construct a 3D model of the tissue specimen. mRNA
molecules from the cell are released by permeabilization of the tissue allowing it to
diffuse toward the surface and hybridize to the barcoded array. Hybridized material is
subsequently processed into cDNA and sequenced using next-generation sequencing. b:
Computational analysis. One of the well-known analyses is clustering the regions with
similar transcription profiles using unsupervised methods following differential expression
analysis. We can also integrate this spatially-annotated information with single-cell
RNA-seq data to increase the resolution leading to cell types and cell states identification
and elaborate cell-cell communication of co-localized cells.
tissues or even whole organs through mRNA positioning and aggregating a few cells
to subcellular resolution. ST data can also be integrate with single-cell characteristics
using proposed computational approaches to present a more comprehensive view toward
a cellular architecture of the tissue. Figure 5.1 shows experimental and computational
approaches for ST data.
The early version of ST technology used a microarray consisting of ∼ 1000 spots, each
with a diameter of 100 µm, and thus provided an averaged transcriptomic profile from a
mixture of tens of cells [216]. This technology was further enhanced and commercialized
by 10×Genomics in their Visium protocol [220] increasing the resolution to ∼ 5000 spots,
each diameter of 55 µm. Depending on tissue type and thickness, a spot’s resolution
facilitates averaged gene expression measures from 1 to 10 cells, consequently moving
closer to single-cell resolution. This resolution can be further increased by reducing the
spots’ dimensions, which would require more precise printing technology. [219] A more
general challenge for ST technology is to balance the mRNA acquisition performance.
These parameters are controlled by tissue permeabilization conditions, which must be
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optimized for each tissue type to ensure a high cDNA yield and robust demultiplexing of
spatial positions. Besides, like other sequence-based transcriptome assays, the conversion
of mRNA to cDNA poses a confounding factor that needs to be addressed to further
improve the quality of the data, leading to reduced transcript dropout rates [219].
Complex diseases can be analyzed using ST technology to understand their origin and
progression. For instance, ST technology was utilized to identify transcriptional changes
in different spinal cord regions over time to understand the progression of amyotrophic
lateral sclerosis [221]. These regional differences in the early stages of the disease, es-
tablished key steps in motor neuron degeneration and disease-associated pathways. ST
data was also used in Alzheimer’s to identify transcriptional changes in tissue domains
surrounding amyloid plaques [222]. These studies provide examples of how the integra-
tion of two modalities of data, including transcriptome and tissue-wide data can be used
to understand cellular mechanisms underlying neurological diseases.
In cancer disease, there are complex networks of cell-cell interactions in the tumor
microenvironment, which can be analyzed using unbiased transcriptome sequencing tech-
niques to understand potential signaling pathways for a new therapeutic hypothesis. A
previous study characterized tumor-specific expression profiles of multifocal prostate can-
cer sites, together with stromal and immune cells [223]. This unbiased analysis of the
tumor revealed that cancer-associated expression patterns appeared in regions where
histological evidence was absent, highlighting the potential of spatially resolved tran-
scriptomics to capture signals that are otherwise missed by conventional histopathology.
For example, previous studies integrated single-cell RNA-seq data with histological data
on pancreatic ductal adenocarcinoma and squamous cell carcinoma [224, 225] to decon-
volve spatial expression profiles in silico and thereby determine the spatial positions of
cell types within the tissue. These approaches enabled data-driven annotations of cellu-
lar structure and promoted understanding of cellular interactions by decoding spatially
colocalized cells. These studies highlight the importance of ST technology to overcome
the heterogeneity of cancers. Unbiased identification of cellular communication networks
will continue to deepen our understanding of cancer pathogenesis and holds the potential
to accelerate the discovery of new therapeutic targets and more sophisticated approaches
for treatment [219].
In the aforementioned approaches, the focus is predominantly on morphology and
expression and regulatory mechanisms are often overlooked. Identifying gene regulatory
interactions is an important element to obtain a systematic view underlying a complex
trait. Detecting regulatory mechanisms in ST data aid in understanding the underlying
molecular mechanisms of spatial and temporal expression patterns within the tissue
[221]. So far, the spatial regulation has been largely under-exploited, and computational
methods for this goal his lacking. In this section, we investigate a possible solution to
detect morphological variations associated with candidate regulatory interactions using
spatial expression pattern in local regions. We believe that the local features holds
valuable information for interrogating spatial regulatory patterns leading to accurately
built local regulatory networks.
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Figure 5.2: The stained breast tumor slide on the spatially-featured spots.
5.2 Materials and methods
5.2.1 Data preparation
The spatial gene expression data was downloaded from 10× Genomics online repository
[220]. The data was obtained from fresh frozen Invasive Ductal Carcinoma breast tissue
that was embedded and cryosectioned as described in Visium Spatial Protocol [220].
Tissue sections of 10 µm thickness were placed on Visium Gene Expression Slides. The
slide was coverslipped, and the H&E image was acquired using a microscope with 20×
magnification. The tissue was ER-positive, PR-negative, HER2-positive, and annotated
with Ductal carcinoma in situ. Gene expression library was prepared following the
Visium Spatial Gene Expression Reagent Kits and was sequenced on an Illumina NovaSeq
6000 [226] with sequencing depth 150,392 reads per spot. The key cell metrics were: 1 -
Spots detected under tissue: 3,798, 2 - Median UMI counts per spot: 20,762 , 3 - Median
genes per spot: 6,026. Figure 5.2 is the tissue image on the spatially-featured spots.
5.2.2 Data exploration and preprocessing
It is stated that "The Visium data consists of the following data types: 1- A spot by gene
expression matrix, 2 - An image of the tissue slice (obtained from H&E staining during
data acquisition), 3 - Scaling factors that relate the original high-resolution image to the
lower resolution image used here for visualization" [227]. We used the Seurat package in
R [228] to process and analyze the data. The scripts used for this section utilized directly
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Figure 5.3: The variance in molecular counts across spots and tissue.
from Seurat package’s tutorial to analyze spatially-resolved RNA-seq data [227]. The
spatially-barcoded gene expression matrix is maintained in the Seurat object, similar to
typical RNA-seq data, including spot identifiers instead of cell identifiers. The image
itself is stored in a new image slot in the Seurat object, storing the required information
to overlay spots on the image data [227].
Normalizing the spot by gene expression matrix is the first preprocessing step sim-
ilar to scRNA-Seq data to handle the variance in sequencing depth [227]. Note that
the variance in molecular counts/spot can be substantial for spatial datasets, particu-
larly if there are differences in cell density across the tissue. We observed substantial
heterogeneity, which required effective normalization. Figure 5.3 illustrates the variance
in molecular counts across spots and tissue. The expression pattern across spots shows
that the variance in molecular counts depends on the tissue morphology, not just tech-
nical variance [227]. Therefore, several common approaches, such as the LogNormalize
function, are not efficient here since they enforce the data point to have the same size.
It is stated that "Hafemeister et al. [229] built a regularized negative binomial model
of gene expression in order to account for technical artifacts while preserving biological
variance" [227].
We utilized the SpatialFeaturePlot function in Seurat, which enables us to analyze
and visualize the spatial data interactively in an overlaid format of the expression data
and the tissue histology. For example, in Figure 5.4, we visualized overlaid tissue and
expression value of TP53, HER2, ESR1 (estrogen receptor), and PGR (progesterone
receptor) to validate molecular annotations on the tumor sample. We validated the
molecular annotations that the tumor sample is HER2-, ER-positive, and PR-negative.
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Figure 5.4: The Visualization of overlaid tissue and expression value of TP53, HER2,
ESR1 (estrogen receptor) and PGR (progesterone receptor) to validate molecular anno-
tations on the tumor sample.
5.3 Results
5.3.1 Dimensionality reduction and clustering,
Just like other high-dimensional omics data, ST datasets are profiled a large number of
spots, which required dimensional reduction algorithms to project it to a low-dimensional
space and visualize the clusters across the tissue section [230]. Linear dimension reduc-
tion methods such as Principal Component Analysis (PCA) cannot capture the complex
structures of spatial transcriptomic data in low dimensional spaces. However, accord-
ing to the previous studies analyzing scRNA-Seq data, nonlinear dimension reduction
methods such the t-distributed stochastic neighbor embedding algorithm (t-SNE) [231]
has shown robust outputs [230]. We used t-SNE dimension reduction to map the spots
into a lower dimension and visualize them based on their expression pattern. Next, we
mapped the clusters into the tissue section to see where the clusters mapped to capture
the spatial location of each cluster relative to others. Figure 5.5 shows the clusters and
mapped tissue image color-coded based on each cluster identifier.
We decided to exclude the clusters dispersed across tissue and only focus on localized
clusters since our goal is to investigate regulatory patterns using co-localized cellular
patterns. To do this, we mapped each cluster separately to the tissue to detect localized
clusters (Figure 5.6). This approach is useful for distinguishing the spatial localization
of individual clusters.
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Figure 5.5: Clustering of spots based on their gene expression pattern usingt-SNE and
mapped tissue image which is color-coded based on each cluster identifier.
Figure 5.6: The spatial localization of individual clusters across the tissue.
The results show that clusters 0 and 7 are the most dispersed clusters, which can
be the candidates to be excluded from the analysis for the section 5.3.3 . We selected a
subset of spots, including only localized clusters. Figure 5.7 represents localized clusters
filtered for further analysis.
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Figure 5.7: The clustering results excluding dispersed clusters.
5.3.2 Identification of spatially variable features
We applied a differential gene expression analysis to identify significant markers asso-
ciated with spatial locations within a tissue. This step can be done using annotated
anatomical regions determined by either prior knowledge or unsupervised clustering
[227]. This strategy works well in our case, as the clusters above exhibit clear spatial
restrictions. There are two approaches to perform differential gene expression analysis.
The first one is to identify DEGs comparing to local clusters. The second one is to per-
form a globally DEG analysis to compare one cluster versus the rest. In our analysis, we
identified markers for every cluster compared to all remaining spots. Figure 5.8 shows
a heatmap presenting the top 10 globally deferentially expressed genes in each tissue
along with their expression signal corresponding to other clusters. As can be seen, the
top 10 markers are expression significantly in local clusters compared to others. Figure
5.9 shows the tissue heatmap corresponding to the top DEG in each cluster, reflecting
the expression signal unique to the cluster.
Next, we aimed to identify cell types enriched in the clusters according to their
spatially expressed genes. We used reported canonical markers associated with Breast
cancer tumor microenvironment revealed by single-cell profiling [232]. We manually cu-
rated these markers for each cell type and used them to analyze our clusters. We listed
top enriched markers for each cluster sorted based on their adjusted P-value along with
their cell type (Table 5.1). As we discussed previously, cluster 0 is one of the two dis-
persed clusters mapped on the tissue slide. Table 5.1 shows that cluster 0 is mostly
enriched with Fibroblast and Immune cells. AEBP1 and COL1A1 are fibroblast-specific
markers that are involved in the extracellular matrix organization process. These fi-
broblast cells that are commonly found in connective tissues and extracellular matrix
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Figure 5.8: Top 10 deferentially expressed genes in each cluster.
Figure 5.9: The tissue heatmaps corresponding the top DEG in each cluster reflecting
the highly expression signal which is unique to the cluster.
can be detectable features in H&E slides using CNNs. This distributed structure of this
cluster may be due to a specific state of transition of particular immune cells that are
enriched in this cluster, such as tumor-infiltrating immune cells (CD4 T cells). There-
fore, existing both innate and adaptive immune cells in this dispersed cluster, verifies
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one of the important characteristics of the tumor microenvironment. There was only
SLC39A6 gene in our list enriched in cluster 1, which dominantly shows the existence
of Luminal Epithelial cells. Table 5.1 shows that other localized clusters are enriched
with unique or mixed of both Endothelial and Epithelial cells. The result also shows
the existence of fibroblast and immune cells in cluster 7, which is the second dispersed
cluster. Coexpression of CD141 and CD163 (also expressed in clusters 7 and 0) has been
shown that are expressed in tissues responding to acute inflammation and is mediated
by the tumor necrosis factor-α (TNF-α) [233].
Table 5.1: Identifying cell types enriched in the clusters.
Gene Cluster Adjusted P-Value Cell Type
AEBP1 0 1.28e-134 fibroblasts
COL1A1 0 4.98e-117 fibroblasts
COL6A3 0 2.38e-105 fibroblasts
MMP2 0 1.61e-90 fibroblasts
CD14 0 9.84e-86 Myeloid
CD27 0 5.73e-61 B-cell
CD4 0 3.11e-57 T-cell
IL7R 0 2.7e-49 B-cell
SLC39A6 1 1.53e-181 luminal epithelial
KRT18 2 1.2e-211 T-cell
IFI27 2 1.52e-44 vascular endothelial
COMP 2 4.24e-14 luminal epithelial
CCL211 3 1.22e-12 lymphatic endothelial
CLDN5 3 1.77e-14 lymphatic endothelial
RNASE11 3 2.46e-50 vascular endothelial
ACKR11 3 6.01e-15 endothelial
EFHD1 4 1.95e-126 luminal epithelial
KRT181 4 2.58e-117 luminal epithelial
HES1 4 2.61e-55 luminal epithelial
KRT5 5 2.13e-97 basal epithelial
KRT6B 5 2.26e-84 basal epithelial
KRT14 5 1.38e-63 basal epithelial
MMP7 5 1.45e-19 basal epithelial
FCGR3B 6 2.31e-171 myeloid
AEBP12 7 2.91e-21 fibroblasts
COMP2 7 3.71e-14 fibroblasts
CD141 7 5.84e-13 myeloid
IFI272 8 2.390e-76 vascular endothelial
CD241 8 3.71e-64 B-cell
CITED4 8 2.89e-37 basal epithelial
EFHD11 8 2.531e-14 luminal epithelial
LC39A61 8 1.43e-45 luminal epithelial
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Figure 5.10: The spatial gene expression of top predicted TFs corresponding to each clus-
ter recovered by CIE. The results demonstrate a significant local pattern that determines
gene regulatory interaction between transcription factor and target gene.
5.3.3 Applying CIE to infer potential upstream regulators
In this section, we incorporated CIE, presented in Chapter 2, to infer active upstream
regulators underlying the observed patterns of up- and down-regulated transcripts. We
extracted top differentially expressed genes in each cluster and used this input to run
the causal inference analysis. Next, the predicted regulators were sorted based on their
enrichment score, and we tried to inspect their spatial expression pattern on the tissue.
Interestingly, the results demonstrate a significant local pattern determining gene reg-
ulatory interaction between transcription factors and target genes. Figure 5.10 shows
spatial gene expression patterns for the top predicted TF for each cluster, which clearly
illustrates the co-localization expression pattern of gene regulatory interaction. These
results suggest that the integrative analysis of spatial transcriptomic data with CIE can
capture discriminant features from the image to recognize TF-target links. Note that
the unsupervised or the traditional supervised methods are unable to provide this source
of information.
These patterns can provide information on active regulatory mechanisms overlaid on
the tissue image. A similar approach was recently used in a deep learning framework to
predict gene regulatory interaction that outperformed traditional methods with a large
margin and reveals new intriguing knowledge about cellular interaction and signaling
mechanisms [234]. Furthermore, by integrating ST data and scRNA-seq data, we can
improve the resolution to distinguish cell types corresponding to each cluster leading
to spatial cell-cell communication, determine the spatial scale of particular types of
intercellular signaling, and recognize gene pairs that potentially intercellularly regulate
each other [235].
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5.4 Conclusion and discussion
In the last few years, spatial transcriptomic data has enabled research studies to infer
new biological insight based on spatial patterns of gene expression. Available methods
based on unsupervised approaches [234] mostly depend on image similarity that cannot
extract local patterns corresponding to regulatory interactions between TF and target
genes. Spatial transcriptomic data can provide useful information to understand gene
regulatory patterns that weren’t possible by previous technologies. However, Spatial
transcriptomic data are required to be integrated with another source of information to
produce reliable results due to noisy data or irrelevant features [234].
This chapter presented an integrated analysis of ST data combined with causal infer-
ence to predict putative regulatory interaction in a spatially resolved manner, leading to
a supervised model for TF-target morphological prediction. We utilized ST gene expres-
sion from 10X genomics database associated with HER2-positive breast cancer tumor.
Differential gene expression analysis identified markers corresponding to cell clusters, on
which CIE was applied to infer upstream regulators. We found significant co-localization




In this thesis, we have introduced novel models and approaches for learning gene reg-
ulatory pattern and cellular morphology in cancer using molecular and imaging data.
The models and platforms that I have developed are general and are widely applicable
to several problems relating to dysregulation of gene expression in diseases. Moreover, I
have developed pipelines and software packages that are disseminated in public reposi-
tories for the larger scientific community use. We see this as highly imperative in the era
where AI technology is becoming more commercialized and not available to academics.
In summary, our contributions and possible avenues of future work are:
(a) In chapter 2, we proposed Causal Inference Engine (CIE), an integrated platform
that identifies active regulators by running probabilistic queries on biological net-
works, in order to identify active regulatory mechanisms from gene-expression data.
The platform consists of a web-server and a user friendly R-package. The platform
provides various inference models, including methods based on the Fisher’s exact
test (enrichment test) as well as a directional enrichment analysis models that can
utilize information on mode of regulation. Moreover, we have presented an ap-
proach based on regularized Gaussian Graphical Models (GGM) to construct an
accurate and high-coverage annotated networks of TF-gene regulatory interactions.
We achieved this by integrating publicly available high-throughput ChIP-Seq ex-
periments deposited in ChIP-Atlas with tissue specific gene expression data from
GTEx. The key steps of our approach include: (i) TF-gene interactions derived
from ChIP-Seq experiments are utilized to construct a penalty matrix encoding
the prior causal graph of TF-gene interactions. (ii) A penalty matrix is utilized
to regularize the log-likelihood of a GGM constructed from tissue-specific gene
expression data, from which a posterior TF-gene interaction is constructed. The
design of the regularization is such that the GGM essentially eliminates the inter-
actions in the prior ChIP-network that are not supported by the expression data,
resulting in posterior tissue-specific and causal ChIP-networks. (iii) The mode of
regulation of the posterior interactions are determined from the partial correlation
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matrix, resulting in network of annotated tissue-specific TF-gene interactions. (iv)
In addition to tissue specific interactions, we determine cross-tissue interactions,
i.e. interactions that appear in multiple tissues and are in a sense ‘Universally
applicable. (v) Subsequently we integrated algorithms in the CIE platform for
directional enrichment analysis that are designed to identify active transcriptional
regulators of differential gene expression data. Taken together, this framework
provides a comprehensive platform with integrated visualization for analysis of
transcriptional regulators.
(b) In chapter3, we proposed a hybrid model ModEx, to mine the biomedical literature
in MEDLINE in order to extract and annotate causal transcriptional regulatory
interactions. Our model incorporates three main components of Information Re-
trieval (IR), Name Entity Recognition (NER) and Information Extraction (IE)
customized for mining regulatory interactions. Several expert-generated dictionar-
ies are provided to optimize and complement the IR component. We proposed
a weighted long-range dependency graph to extract causal relations and anno-
tated the retrieved interaction with meta-data, such as full supporting sentences,
PubMed ID, and importantly mode of regulation. Our pipeline bypasses several
of the challenges of fully automated text-mining methods, including query transla-
tion for a particular interaction, relevant citation retrieval, entities recognition and
regulatory annotation. ModEx was able to achieve an F-score 0.76 in retrieving
and annotating a gold-standard regulatory network. We also compared ModEx
with a state-of-the-art method, and the result shows strong improvement in terms
of classification metrics.
(c) In chapter 4, To investigate how images can be used to distinguish cancer drivers,
we tested the accuracy of CNNs for classifying TP53 mutation status in 5 TCGA
cancer types, namely Breast Invasive Carcinoma (BRCA), LUAD, Stomach Ade-
nocarcinoma (STAD), Colon Adenocarcinoma (COAD) and Bladder Carcinoma
(BLCA). We chose these due to their high TP53 mutation frequency, providing
sufficient testing and training sets for cross-classification analysis. Using transfer
learning, we obtained moderate to low AUCs for TP53 mutant/WT classification
(0.66 for BRCA, 0.64 for LUAD, 0.56 for STAD, 0.56 for COAD, and 0.61 for
BLCA). Next, we used a more computationally intensive approach, where we fully
trained all parameters of the neural networks. We used sampling methods to ad-
dress data imbalance issues and a 70/30 ratio of slides for training and testing. Self-
cohort predictions resulted in AUC values ranging from 0.65- 0.80 for per-slide and
0.63-0.78 for per-tile evaluations. Stomach adenocarcinoma (slide AUC=0.65) was
notably more difficult to predict than lung adenocarcinoma (slide AUC=0.80), for
which we found AUC values comparable to the AUC=0.76 LUAD results reported
by previous study. This LUAD fully-trained network (AUC=0.76) outperformed
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the transfer learning for the same data (AUC = 0.64). We then tested the ability
of the TP53 CNN classifiers to cross-predict across cancer types. Cross predictions
yielded AUC values with a comparable range as the self-cohort analyses (AUCs
0.62- 0.72 for slides; 0.60-0.70 for tiles), although self-cohort analyses were slightly
more accurate. These AUC values are not sufficient for practical use, although the
positive cross-classification results suggest that it might be possible to combine
datasets to increase accuracy. Colon adenocarcinoma AUC values tended to be
low as both a test and train set, suggesting TP53 creates a different morphology in
this tissue type. Overall, the positive cross-classifiabilities support the existence of
shared TP53 morphological features across tissues. We compared the LUAD- and
BRCA-trained deep learning models on these slides, as those two models provided
the highest AUC values in our cross-classification experiments. The BRCA-trained
TP53 mutation status model predicts patterns similar to the LUAD-trained model.
However, a caveat to these analyses is that the spatial variation within heatmaps
may reflect TP53 mutant-associated microenvironmental features rather than ge-
netic variation among cancer cells.
(d) HER2 positive breast cancer is a breast cancer that tests positive for a protein
called human epidermal growth factor receptor 2 (HER2) which promotes the
growth of cancer cells. HER2 positive breast cancers tend to be more aggressive
than other types, and treatments that specifically target HER2 are very effective.
To predict HER2 positive tumors and treatment outcome, we developed a CNN
model that is trained H&E slides manually annotated by our pathologists collabo-
rators at Yale School of Medicine. One particular goal of this project is to use H&E
slides and Deep learning to reduce the cost of diagnostic testing and to leave out
applying more expensive tests on unequivocal cases. Here, we used inception-v3
model to predict breast cancer Her2 status meaning whether the tumor is Her2
positive (Her2+) or negative (Her2-). Predicting HER2 status can have a potential
impact on diagnostic and its relevant cost. For this project, a total of 186 anno-
tated H&E slides were analyzed. Each slide was annually annotated to highlight
the regions corresponding to HER2+/- tumor microenvironment, providing high
resolution images with tile level labels that were utilized to train a more accurate
model. We also investigated whether our model is able to predict the HER2 status
using unannotated slides. The inception v3 was both trained using both fully-
training and transfer learning on randomly assigned of 70% and tested on 30% of
the slides. Our model achieved 0.82 and 0.81 AUCs for fully-trained and transfer
learning respectively. Next, we took annotated regions which are bounding the tu-
mor micro-environment. The goal was to discriminate tumor region with exterior
region including normal, stromal and mixed cells, in which the CNN could learn
more specific features related to HER2+/- tumor status. For this analysis, each
slide was masked, tiled and categorized into Tumor and Other regions (exterior cel-
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lular environment). Therefore, we considered 3 classes including HER2+, HER2-
and other for the classification task. Our model achieved 0.89 and 0.90 AUCs for
fully-trained and transfer learning respectively. This work is still in progress and
I aim to validate our trained model using an external dataset.
(e) In chapter 5, we tried to bridge these last two projects by using spatial tran-
scriptomic data to spatially study gene regulatory interactions on tissues. In fact,
Identifying disrupted regulatory mechanisms in cancer is a challenging and im-
portant task. Our CIE platform provides a way to identify candidate up-stream
regulators from gene expression data. On the other hand, our deep learning models
can identify characteristic features of tumor and its microenvironment from tissue
slide images. We attempted to unify these and identify spatial representation
of regulator-target gene morphology using spatially-resolved transcriptomic data.
As a preliminary step, we utilized human Breast Cancer spatial Gene Expression
Dataset from fresh frozen Invasive Ductal Carcinoma breast tissue samples pro-
vided by 10x Genomics. The tissue samples are ER positive, PR negative, and
Her2 positive. We normalized the data in order to account for variance in sequenc-
ing depth across data points. The variance in molecular counts / spot can be
substantial for spatial datasets, particularly if there are differences in cell density
across the tissue. Indeed, we observed substantial heterogeneity, which required
effective normalization. We then proceeded to run dimensionality reduction and
clustering on the RNA expression data, using the same workflow similar to single-
cell RNA-seq data analysis. Next, we performed a DEG analysis to find markers
corresponding to each cluster following by running CIE as a downstream analysis
to infer upstream transcription factors. We found significant co-localization pat-
terns of TF-target expression is spatially regulated.
I believe that recent technologies have enabled multiple high-throughput omics data
simultaneously measured from a single experiment. For instance, digital pathology pro-
vides image-based biomarkers extracted from multiple imaging data, and spatial tran-
scriptomics captures gene expression and morphological features concurrently from a
tissue sample. These technologies have impacted the field tremendously toward deci-
phering complex diseases such as cancer. Systems biology can play a prominent role in
determining complex interactions between these biological data in parallel layers. While
we see such exciting development in omics research, we don’t have a complete systems
biology framework integrating and analyzing them. Developing such a framework is one
of the crucial unmet needs that enables us a comprehensive view to understand internal
and external factors underlying complex diseases.
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